The Mitochondrial Acylome Emerges: Proteomics, Regulation by Sirtuins, and Metabolic and Disease Implications
Open accessAbstract
Post-translational modification of lysine residues via reversible acylation occurs on proteins from diverse pathways, functions, and organisms. While nuclear protein acylation reflects the competing activities of enzymatic acyltransferases and deacylases, mitochondrial acylation appears to be driven mostly via a non-enzymatic mechanism. Three protein deacylases, SIRT3, SIRT4, and SIRT5, reside in the mitochondria and remove these modifications from targeted proteins in an NAD+-dependent manner. Recent proteomic surveys of mitochondrial protein acylation have identified the sites of protein acetylation, succinylation, glutarylation, and malonylation and their regulation by SIRT3 and SIRT5. Here, we review recent advances in this rapidly moving field, their biological significance, and their implications for mitochondrial function, metabolic regulation, and disease pathogenesis.
AI snapshot
Written from the paper’s full text.
TL;DR
This review argues that mitochondrial lysine acylation is largely a non-enzymatic consequence of reactive acyl-CoA species and is reversed by mitochondrial sirtuins SIRT3, SIRT4, and SIRT5. It synthesizes proteomic and biochemical evidence linking these modifications to mitochondrial metabolism, stress responses, and diseases including metabolic syndrome, cancer, neurological disorders, and hearing loss.
Key findings
- Mitochondrial acylation includes acetylation, succinylation, malonylation, glutarylation, and other acyl marks; SIRT3 is the major mitochondrial deacetylase, SIRT5 removes acidic acyl groups such as succinyl, malonyl, and glutaryl, and SIRT4 remains the least understood but has been linked to lipoyl, biotinyl, and branched-chain acyl modifications.
- Proteomic surveys mapped thousands of sites: for example, 2,187 acetylation sites in 483 mouse liver mitochondrial proteins, with 283 sites in 136 proteins increased more than twofold in SIRT3-deficient mice; 2,565 succinylation sites in 779 proteins in SIRT5-deficient liver and MEFs; and 1,137 malonylation sites in 430 proteins, with 183 sites increased in SIRT5 knockout liver.
- Acylation is often inhibitory for mitochondrial enzymes, and sirtuin-mediated removal can activate pathways such as fatty acid oxidation, ketone body synthesis, the urea cycle, and oxidative stress defense; examples include PDH, HMGCS2, CPS1, OTC, MnSOD, and IDH2.
- Disease connections include SIRT3 loss with metabolic syndrome, pulmonary arterial hypertension, age-related hearing loss, and context-dependent cancer roles; SIRT5 loss with altered ketone body production, ammonia handling, and glycolysis; and SIRT4 with leucine metabolism and insulin secretion.
Methods
- Narrative review synthesizing published proteomic, biochemical, genetic, and structural studies; no new primary experimental data are reported.
- The paper compares mass-spectrometry strategies for acylation profiling, including label-free quantification, SILAC, isobaric tagging such as TMT, and newer stoichiometry methods.
- Evidence discussed comes from mouse knockout models, cell lines, human tissues, and in vitro enzyme assays, with emphasis on SIRT3 and SIRT5 datasets and selected SIRT4 studies.
Limitations
- Stated: SIRT4’s enzymatic activity and target specificity remain poorly defined; most acylation sites appear to have low stoichiometry, often below 1% for acetylation, raising questions about functional relevance; indirect SILAC-based stoichiometry can overestimate occupancy because lysine carries multiple modifications; and study discrepancies exist, such as the 28% versus 79% overlap reported between succinylation and acetylation sites.
- Stated: the mechanisms connecting acylation changes to whole-organism disease phenotypes are largely unknown, and many disease effects are likely mediated by multiple low-occupancy modifications rather than a single site.
- Evident: as a review, the conclusions depend on the cited literature rather than new experiments, and the field lacks comprehensive stoichiometry data for most acyl modifications.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 149 cited sources checked · 0 supported · 0 flagged
- Premisenone given
SIRT3, SIRT4, and SIRT5 are mitochondrial NAD+-dependent deacylases that remove acyl modifications from target proteins.
“Three protein deacylases, SIRT3, SIRT4 and SIRT5 reside in the mitochondria and remove these modifications from targeted proteins in an NAD+-dependent manner.”
Quote in the paperSubstantial claim - Interpretationcitation
SIRT3 is the major mitochondrial protein deacetylase.
“Early experiments using western blotting analysis and antisera specific for acetyl-lysine showed globally increased mitochondrial protein acetylation in mice lacking SIRT3 ((Lombard et al. 2007)), indicating that SIRT3 was the major mitochondrial protein deacetylase.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Lombard et al. 2007 source
Not checked in the free run.
- Premisecitation
Patients with MCD deficiency exhibit increased protein malonylation.
“Similarly, and from the same study, human SCAD-deficient fibroblasts show increased lysine butyrylation, patients with malonyl-CoA decarboxylase (MCD) deficiency exhibit increased protein malonylation and finally, propionyl-CoA carboxylase (PCC) deficient patient cells show increased lysine propionylation.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Pougovkina et al. 2014 source
Not checked in the free run.
- Premisecitation
Loss of SIRT3 exacerbates hypernutrition-induced impairment of skeletal muscle glucose uptake.
“However, prolonged hypernutrition leads to type 2 diabetes, and has been shown to impair skeletal muscle glucose uptake in a manner exacerbated by the loss of SIRT3 (Jing et al. 2013),(Lantier et al. 2015).”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
Loss of SIRT3 inhibits fatty acid oxidation.
“Loss of SIRT3 has been shown to inhibit fatty acid oxidation ((Hirschey et al. 2010)); the same study showed decreased gluconeogenic production of glucose in response to cold challenge and decreased production of the ketone body beta-hydroxybutyrate during fasting.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Hirschey et al. 2010 source
Not checked in the free run.
- Interpretationreasoning
Some mitochondrial acetylation sites may be regulated by glutathione redox balance and glyoxalase II in addition to mitochondrial sirtuins.
“This redox-sensitive mechanism means that certain acetylation sites observed in mitochondria may be regulated by glutathione redox balance and glyoxalase II in addition to mitochondrial sirtuins.”
Quote in the paperNot a substantial claim - Interpretationreasoning
Other acylation modifications are likely to be affected by thiol proximity in the same way as acetylation and succinylation.
“This mechanism has been shown to affect both acetylation and succinylation; other acylation modifications are likely to be similarly affected.”
Quote in the paperNot a substantial claim - Premisecitation
Obesity from hypernutrition predominantly decreases mitochondrial acetylation in liver.
“In contrast to fasting and calorie restriction, hypernutrition to the point of obesity has been shown to predominantly decrease mitochondrial acetylation in liver (Still et al. 2013).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Still et al. 2013 source
Not checked in the free run.
- Premisecitation
SIRT3 is upregulated during fasting.
“SIRT3 is upregulated during fasting (Hirschey et al. 2010) and more generally by PGC-1α (Kong et al. 2010), which allows it to best control the hyperacetylation caused by acetyl-CoA-dependent metabolic processes such as fatty acid oxidation and ketone body metabolism.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Hirschey et al. 2010 source
Not checked in the free run.
- Premisecitation
ACAT1 may drive acetylation of PDHA1 and PDP1 by associating with these proteins.
“In particular, acetyl-CoA acetyltransferase (ACAT1), which synthesizes acetoacetyl-CoA by condensing two molecules of acetyl-CoA as a precursor for ketone body synthesis, may be a driving source of acetylation of the pyruvate dehydrogenase complex component PDHA1 and its activating phosphatase PDP1 by associating with these proteins ((Fan et al. 2014)).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Fan et al. 2014 source
Not checked in the free run.
- Interpretationreasoning
Local mitochondrial concentrations of individual acyl-CoAs are likely modulated by intercompartmental trafficking.
“Local mitochondrial concentrations of individual acyl-coAs is also likely to be modulated via intercompartmental trafficking.”
Quote in the paperNot a substantial claim - Premisecitation
The thiol-proximity mechanism affects both acetylation and succinylation.
“This mechanism has been shown to affect both acetylation and succinylation; other acylation modifications are likely to be similarly affected.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites James et al. 2017 source
Not checked in the free run.
- Premisecitation
Human SCAD-deficient fibroblasts show increased lysine butyrylation.
“Similarly, and from the same study, human SCAD-deficient fibroblasts show increased lysine butyrylation, patients with malonyl-CoA decarboxylase (MCD) deficiency exhibit increased protein malonylation and finally, propionyl-CoA carboxylase (PCC) deficient patient cells show increased lysine propionylation.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Pougovkina et al. 2014 source
Not checked in the free run.
- Premisecitation
Calorie restriction causes mitochondrial hyperacetylation in liver, kidney, and heart.
“Metabolic supplier organs such as the liver and kidney demonstrate mitochondrial hyperacetylation under CR, as does the heart (Schwer et al. 2009); brain mitochondrial acetylation was unchanged, however, and skeletal muscle acetylation decreased.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Schwer et al. 2009 source
Not checked in the free run.
- Interpretationreasoning
If the non-enzymatic mechanism for mitochondrial lysine acylation holds, the relative abundance of distinct acyl-CoA species is the main force driving differences in acylation between tissues.
“If the emerging non-enzymatic mechanism for mitochondrial lysine acylation holds, the relative abundance of distinct acyl-CoA species represent the main force driving differences in acylation between tissues.”
Quote in the paperSubstantial claim - Interpretationcitation
The intramolecular context of mitochondrial protein lysines affects how likely they are to be acylated.
“The intramolecular context for mitochondrial proteins’ lysines affects how likely they are to be acylated.”
Quote in the paperNot a substantial claim - Premisecitation
PCC-deficient patient cells show increased lysine propionylation.
“Similarly, and from the same study, human SCAD-deficient fibroblasts show increased lysine butyrylation, patients with malonyl-CoA decarboxylase (MCD) deficiency exhibit increased protein malonylation and finally, propionyl-CoA carboxylase (PCC) deficient patient cells show increased lysine propionylation.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Pougovkina et al. 2014 source
Not checked in the free run.
- Premisecitation
Proximity to thiols such as cysteine residues increases the rate of acylation for nearby lysines.
“As an added twist on semi-enzymatic acylation, proximity to thiols such as those provided by cysteine residues apparently increases the rate of acylation for nearby lysines (James et al. 2017).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites James et al. 2017 source
Not checked in the free run.
- Interpretationreasoning
Lysine pKa influences the level of non-enzymatic modification of specific lysines.
“Another variable likely to influence the level of non-enzymatic modification of specific lysines is their pKa.”
Quote in the paperNot a substantial claim - Interpretationreasoning
Mitochondrial hyperacetylation tends to limit the metabolic adaptations needed for proper function during fasting.
“Mitochondrial hyperacetylation thus tends to limit the metabolic adaptations necessary for proper function during fasting; SIRT3 is upregulated during fasting to combat this process (Hirschey et al. 2010), and many mitochondrial proteins are hyperacetylated during fasting (Still et al. 2013).”
Quote in the paperSubstantial claim - Premisecitation
Divalent acyl-CoAs such as succinyl-CoA and glutaryl-CoA can use the anhydride route to acylate lysines faster than monovalent acyl-CoAs such as acetyl-CoA.
“Divalent acyl groups such as succinyl- and glutaryl-CoA can use this alternative non-enzymatic reaction mechanism to achieve higher reaction rates than monovalent acyl species such as acetyl-CoA.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Wagner et al. 2017 source
Not checked in the free run.
- Premisecitation
Many mitochondrial proteins are hyperacetylated during fasting.
“Mitochondrial hyperacetylation thus tends to limit the metabolic adaptations necessary for proper function during fasting; SIRT3 is upregulated during fasting to combat this process (Hirschey et al. 2010), and many mitochondrial proteins are hyperacetylated during fasting (Still et al. 2013).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Still et al. 2013 source
Not checked in the free run.
- Interpretationreasoning
It is likely that no general mitochondrial acyltransferase exists.
“As nuclear and cytosolic acylation are driven by acyltransferases, a considerable amount of work has been poured into finding a mitochondrial acyltransferase to little success; it seems likely that no such general acyltransferase exists.”
Quote in the paperNot a substantial claim - Premisecitation
Some acyl-CoA species can modify lysine residues through a cyclic anhydride intermediate.
“Recent work has further shown that some acyl-CoA species can modify lysines via a cyclic anhydride intermediate (Wagner et al. 2017).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Wagner et al. 2017 source
Not checked in the free run.
- Premisecitation
Lysine acetylation has been observed on DLD and PDHA1 at multiple residues.
“Lysine acetylation has been observed on DLD and PDHA1 at multiple residues ((Rardin, Newman, et al. 2013)), but a functional role for acetylation has only been demonstrated for modification of lysine 321 of PDHA1 ((Jing et al. 2013)).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Rardin, Newman, et al. 2013
Not checked in the free run.
- Premisecitation
NAD+ supplementation in C. elegans extends worm lifespan via induction of the mitochondrial unfolded protein response and upregulation of mitochondrial superoxide dismutase.
“Supplementation of NAD+ levels in C elegans ((Mouchiroud et al. 2013)) extends worm lifespan via the induction of the mitochondrial unfolded protein response and upregulation of mitochondrial superoxide dismutase.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Mouchiroud et al. 2013 source
Not checked in the free run.
- Interpretationreasoning
Neutralization of positively charged protein patches by negatively charged acyl groups likely represents a shared mechanism for enzymatic inhibition.
“Neutralization of these positive patches by conjugating negatively charged acyl groups is thus likely to represent a shared mechanism for enzymatic inhibition.”
Quote in the paperSubstantial claim - Interpretationreasoning
Most mitochondrial acylation appears to be functionally inhibitory in the enzymes in which it has been tested.
“Most mitochondrial acylation appears to be functionally inhibitory in enzymes in which it has been tested.”
Quote in the paperSubstantial claim - Premisecitation
Exogenous NAD+ or precursor compounds that are converted to NAD+ in vivo can enhance tissue function and health.
“Addition of exogenous NAD+, or precursor compounds which are converted to NAD+ in vivo, is currently a hot topic in the field of aging biology due to recent successes in enhancing tissue function and health ((Yoshino et al. 2011), (Canto et al. 2012)).”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
SIRT3 deacetylates and activates acetyl-CoA synthetase 2 at K642 in the human protein or K635 in mice.
“SIRT3 also deacetylates (at K642 in the human protein or K635 in mice) and activates acetyl-CoA synthetase 2, an enzyme in extrahepatic tissues that activates acetate into acetyl-CoA ((Schwer et al. 2006); (Hallows, Lee, and Denu 2006)).”
Quote in the paperSubstantial claim0 of 2 sources checked - Premisecitation
SIRT3 promotes efficient lipid utilization during fasting by activating long-chain acyl-CoA dehydrogenase via deacetylation at K42.
“SIRT3 promotes the efficient utilization of lipids as a primary source of acetyl-CoA during fasting by activating long-chain acyl-CoA dehydrogenase, a key enzyme in the β-oxidation of fatty acids, via deacetylation at K42 ((Hirschey et al. 2010)).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Hirschey et al. 2010 source
Not checked in the free run.
- Premisecitation
SIRT3 deacetylates PDHA1 K321.
“First, SIRT3 deacetylates K321 and second, SIRT3 also deacetylates PDP, enhancing its phosphatase activity on PDC and thereby decreasing PDC phosphorylation. ((Fan et al. 2014)).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Fan et al. 2014 source
Not checked in the free run.
- Premisecitation
A functional role for acetylation has only been demonstrated for modification of PDHA1 lysine 321.
“Lysine acetylation has been observed on DLD and PDHA1 at multiple residues ((Rardin, Newman, et al. 2013)), but a functional role for acetylation has only been demonstrated for modification of lysine 321 of PDHA1 ((Jing et al. 2013)).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Jing et al. 2013 source
Not checked in the free run.
- Premisecitation
NAD+ supplementation results in production of N-methylnicotinamide via sirtuins.
“As NAD+ supplementation also results in potentially beneficial production of N-methylnicotinamide via sirtuins ((Schmeisser et al. 2013)), evidence such as the link to MnSOD affirms roles for acylation both as a direct effector modulated by NAD+ and in transducing NAD+ into an N-methylnicotinamide signal.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Schmeisser et al. 2013 source
Not checked in the free run.
- Premisecitation
Mice lacking SIRT3 share characteristics of human fatty acid oxidation disorders, including cold intolerance and reduced basal ATP levels.
“These mice also share other characteristics of human disorders of fatty acid oxidation, including cold intolerance and reduced basal ATP levels ((Hirschey et al. 2010)).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Hirschey et al. 2010 source
Not checked in the free run.
- Premisecitation
SIRT3 is upregulated by PGC-1α.
“SIRT3 is upregulated during fasting (Hirschey et al. 2010) and more generally by PGC-1α (Kong et al. 2010), which allows it to best control the hyperacetylation caused by acetyl-CoA-dependent metabolic processes such as fatty acid oxidation and ketone body metabolism.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Kong et al. 2010 source
Not checked in the free run.
- Premisecitation
All four enzymes involved in hepatic ketogenesis are heavily modified by lysine acylations including acetylation, succinylation, glutarylation, and malonylation.
“Interestingly, all the four enzymes involved in this process (Thiolase, HMG-CoA synthase, HMG-CoA lyase, and βOHB dehydrogenase) are heavily modified by lysine acylations including acetylation, succinylation, glutarylation and malonylation ((Rardin, Newman, et al. 2013))((Rardin, He, et al. 2013))((Park et al. 2013))((Tan et al. 2014))((Nishida et al. 2015)).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Rardin, Newman, et al. 2013
Not checked in the free run.
- cites Rardin, He, et al. 2013
Not checked in the free run.
- cites Park et al. 2013 source
Not checked in the free run.
- Premisecitation
There is a strong overlap between lysines modified by different acyl groups such as acetylation and succinylation.
“As discussed above, a strong overlap between lysines modified by different acyl groups such as acetylation and succinylation has been noted (Rardin, He, et al. 2013).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Rardin, He, et al. 2013
Not checked in the free run.
- Premisecitation
Protein acetylation in other cellular compartments can be either inhibitory or activating.
“This stands in contrast to protein acetylation in other cellular compartments which can be either inhibitory or activating ((Choudhary et al. 2014)).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Choudhary et al. 2014 source
Not checked in the free run.
- Interpretationcitation
Increasing evidence supports an important role for lysine acylation and sirtuins in regulating ketone body biosynthesis.
“Increasing evidence support an important role for lysine acylation and sirtuins in regulating ketone body biosynthesis.”
Quote in the paperSubstantial claim - Premisecitation
Mice lacking SIRT3 accumulate β-oxidation precursors and intermediates, including triglycerides and long-chain fatty acids.
“Mice lacking SIRT3 accumulate β-oxidation precursors and intermediates, including triglycerides and long-chain fatty acids.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Hirschey et al. 2010 source
Not checked in the free run.
- Premisecitation
SIRT4 is upregulated as part of the DNA damage response via ATF4.
“Similarly, SIRT4 is upregulated as part of the DNA damage response via ATF4 (Jeong et al. 2013).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Jeong et al. 2013 source
Not checked in the free run.
- Premisecitation
Ketone bodies possess signaling activities.
“In addition to its crucial role in intermediary metabolism, ketone bodies also possess signaling activities (Newman & Verdin, 2014).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Newman & Verdin, 2014 source
Not checked in the free run.
- Premisecitation
SIRT5 desuccinylates HMGCS2 at multiple lysine residues, including K83 and K310 near the substrate binding site of the catalytic pocket.
“SIRT5, on the other hand, desuccinylates HMGCS2 at multiple lysine residues; two of the top regulated sites, K83 and K310, are in close proximity to the substrate binding site of the catalytic pocket ((Rardin, He, et al. 2013)).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Rardin, He, et al. 2013
Not checked in the free run.
- Premisecitation
Mutation of HMGCS2 lysines 310, 447, and 473 to arginines enhances HMGCS2 enzymatic activity.
“In agreement with this model, mutation of these lysines to arginines, which prevent acetylation, enhance HMGCS2 enzymatic activity ((Shimazu et al. 2010)).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Shimazu et al. 2010 source
Not checked in the free run.
- Premisecitation
SIRT3 deacetylates OTC at lysine 88.
“It targets the other mitochondrial enzyme, ornithine transcarboxylase (OTC), by deacetylation of lysine 88 ((Hallows et al. 2011)).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Hallows et al. 2011 source
Not checked in the free run.
- Premisecitation
SIRT3 deacetylates HMGCS2 at lysines 310, 447, and 473.
“SIRT3 deacetylates HMGCS2 at lysines 310, 447, and 473 ((Shimazu et al. 2010)).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Shimazu et al. 2010 source
Not checked in the free run.
- Premisecitation
OTC lysine 88 is also a target of succinylation and glutarylation.
“Interestingly, lysine 88 is also a target of succinylation and glutarylation ((Rardin, He, et al. 2013))((Tan et al. 2014)).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Rardin, He, et al. 2013
Not checked in the free run.
- cites Tan et al. 2014 source
Not checked in the free run.
- Premisecitation
HMGCS2 is also subject to glutarylation and malonylation.
“Moreover, HMGCS2 is also subject to glutarylation and malonylation ((Tan et al. 2014))((Nishida et al. 2015)).”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
Metabolomic analysis of fasted mice lacking SIRT3 shows metabolite alterations in the urea cycle.
“Metabolomic analysis of fasted mice lacking SIRT3 shows metabolite alterations in the urea cycle ((Hallows et al. 2011)).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Hallows et al. 2011 source
Not checked in the free run.
- Premisecitation
SIRT5 positively regulates CPS1 activity by mediating desuccinylation, deglutarylation, and possibly deacetylation across multiple sites.
“SIRT5 positively regulates CPS1 activity by mediating desuccinylation, deglutarylation and possibly by deacetylation across multiple sites ((Du et al. 2011))((Tan et al. 2014))((Nakagawa et al. 2009)).”
Quote in the paperSubstantial claim0 of 3 sources checked - Premisecitation
Almost every ketogenesis enzyme contains at least one site subject to SIRT3 or SIRT5 regulation.
“Certain enzymes contain more than a dozen modified sites and almost every enzyme contains at least one site subject to SIRT3 or SIRT5 regulation.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Rardin, Newman, et al. 2013
Not checked in the free run.
- cites Rardin, He, et al. 2013
Not checked in the free run.
- Premisecitation
The urea cycle was the first metabolic pathway found to be regulated by mitochondrial sirtuins.
“The urea cycle was the first metabolic pathway found to be regulated by mitochondrial sirtuins ((Nakagawa et al. 2009)).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Nakagawa et al. 2009 source
Not checked in the free run.
- Premisecitation
CPS1 is a target of lysine acetylation, succinylation, glutarylation, and malonylation.
“CPS1, which catalyzes the initial step of the urea cycle by synthesizing carbamoyl phosphate from ammonia and bicarbonate, is a target of lysine acetylation, succinylation, glutarylation and malonylation ((Nakagawa et al. 2009))((Rardin, Newman, et al. 2013))((Du et al. 2011))((Rardin, He, et al. 2013))((Park et al. 2013))((Tan et al. 2014))((Nishida et al. 2015)).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Nakagawa et al. 2009 source
Not checked in the free run.
- cites Rardin, Newman, et al. 2013
Not checked in the free run.
- cites Du et al. 2011
Not checked in the free run.
- Premisecitation
SIRT4 controls tumorigenesis by inhibiting the high rate of glutamine metabolism associated with cancer growth.
“SIRT4 likewise appears to control tumorigenesis ((Jeong et al. 2013), (Csibi et al. 2013)) by inhibiting the high rate of glutamine metabolism associated with cancer growth;”
Quote in the paperSubstantial claim0 of 2 sources checked - Interpretationnone given
A growing body of evidence links disturbances in mitochondrial protein acylation with unique diseases, typically using whole-body genetic knockout mice and human gene mutations.
“A growing body of evidence links disturbances in mitochondrial protein acylation with unique diseases, typically using whole-body genetic knockout mice but also via identification of mutations in human genes.”
Quote in the paperSubstantial claim - Premisecitation
SIRT3 attenuation of reactive oxygen species production appears to inhibit a glycolytic shift in potentially cancerous cells.
“SIRT3’s attenuation of reactive oxygen species production appears to inhibit a glycolytic shift in potentially cancerous cells ((Finley et al. 2011); (Fan et al. 2014)).”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
Studies have indicated a role for SIRT3 in mediating tumor survival.
“On the other hand, studies have indicated a role in mediating tumor survival ((Alhazzazi et al. 2011);(Cheng et al. 2013)).”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
ADP-ribosylation of glutamate dehydrogenase limits TCA cycle anaplerosis and NAD[P]H generation.
“ADP-ribosylation of glutamate dehydrogenase limits TCA cycle anaplerosis and NAD[P]H generation ((Haigis et al. 2006)), and SIRT4’s delipoylation activity ((Mathias et al. 2014)) also suggests the potential for inhibitory delipoylation of the downstream oxoglutarate dehydrogenase complex, which functions similarly to pyruvate dehydrogenase (discussed above).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Haigis et al. 2006 source
Not checked in the free run.
- Premisecitation
SIRT5 is present in the nucleus and cytoplasm in addition to mitochondria.
“Given that SIRT5 is present in the nucleus and cytoplasm in addition to mitochondria ((Matsushita et al. 2011))((Park et al. 2013))((Nishida et al. 2015)), it will be interesting to test whether SIRT5 modulates the activity of the urea cycle via targeting of both mitochondrial and cytosolic enzymes, or whether one compartment’s effects dominate.”
Quote in the paperSubstantial claim0 of 3 sources checked - Interpretationreasoning
Each disease is likely mediated by multiple presently unidentified acylations, each slightly but cooperatively impairing mitochondrial function.
“Given the generally low stoichiometry of mitochondrial acylation sites, each disease is likely mediated by multiple presently-unidentified acylations, each slightly but cooperatively impairing mitochondrial function.”
Quote in the paperNot a substantial claim- Rests on an assumption: Mitochondrial acylation sites generally have low stoichiometry.
- Premisecitation
SIRT4's overall growth-inhibiting effect results in decreased metabolism and sensitization to glucose inhibition rather than a Warburg-type shift.
“SIRT4 might also seem to drive a dependence on glucose via its inhibition of fat oxidation and glutamine catabolism, but its overall growth-inhibiting effect results in decreased metabolism and a sensitization to glucose inhibition rather than a Warburg-type shift (Jeong et al, JBC 2014).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Jeong et al, JBC 2014 source
Not checked in the free run.
- Interpretationreasoning
SIRT3 can play various roles in tumorigenesis, tumor growth, and metastasis depending on context.
“Given the range of mechanisms giving rise to cancer, it is perhaps unsurprising that SIRT3 can play various roles in tumorigenesis, tumor growth and metastasis depending on context.”
Quote in the paperNot a substantial claim - Premisecitation
SIRT3 also deacetylates key enzymes that produce ROS, such as unique subunits of the electron transport chain and 2-oxoacid dehydrogenases.
“SIRT3 also deacetylates key enzymes that produce ROS such as unique subunits of the electron transport chain ((Rahman et al. 2014)) and 2-oxoacid dehydrogenases ((Quinlan et al. 2014)).”
Quote in the paperNot a substantial claim0 of 2 sources checked - Interpretationnone given
The intermediates linking acylation to associated disease states are not known.
“In contrast to the highly specified molecular sites described above, the intermediates linking acylation to these associated disease states are not known.”
Quote in the paperSubstantial claim - Interpretationcitation
SIRT4 delipoylation activity suggests potential inhibitory delipoylation of the downstream oxoglutarate dehydrogenase complex.
“SIRT4’s delipoylation activity ((Mathias et al. 2014)) also suggests the potential for inhibitory delipoylation of the downstream oxoglutarate dehydrogenase complex, which functions similarly to pyruvate dehydrogenase (discussed above).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Mathias et al. 2014 source
Not checked in the free run.
- Premisecitation
SIRT3 maintains defenses against oxidative damage in the wakefulness-driving nucleus accumbens.
“Recent work on sleep-related cognitive decline found a role in for SIRT3 in maintaining defenses against oxidative damage in the wakefulness-driving nucleus accumbens ((Zhang et al. 2014)).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Zhang et al. 2014 source
Not checked in the free run.
- Premisecitation
SIRT4 inhibits GLUD1 function in pancreatic β cells.
“SIRT4 inhibits GLUD1 function in pancreatic β cells ((Haigis et al. 2006)), raising the possibility that mitochondrial sirtuins might oppose each other to fine tune the activity of urea cycle via modulating different post-translational modifications on various enzymes in this pathway.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Haigis et al. 2006 source
Not checked in the free run.
- Interpretationcitation
SIRT4 is involved in regulation of urea cycle activity.
“Besides SIRT3 and SIRT5, SIRT4 is also involved in the regulation of the urea cycle activity.”
Quote in the paperNot a substantial claim - Interpretationnone given
Mitochondrial protein acylation can suppress the activity of key enzymes that protect against oxidative stress.
“Mitochondrial protein acylation can suppress the activity of key enzymes that protects again oxidative stress.”
Quote in the paperSubstantial claim - Premisenone given
Mice without SIRT3, SIRT4, or SIRT5 show notable metabolic phenotypes that match the pathways reported to be hyperacylated.
“mice lacking SIRT3, SIRT4 or SIRT5 exhibit significant biological metabolic phenotypes that parallel the pathways that are shown to be hyperacylated.”
Quote in the paperNot a substantial claim - Premisecitation
A human SIRT3 polymorphism associated with reduced SIRT3 deacetylase activity is associated with increased risk of metabolic syndrome.
“and a human SIRT3 polymorphism associated with reduced SIRT3 deacetylase activity is associated with increased risk of metabolic syndrome in humans ((Hirschey et al. 2011).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Hirschey et al. 2011 source
Not checked in the free run.
- Premisecitation
Age-dependent decreases in NAD+ limit sirtuin function.
“age-dependent decreases in NAD+ limit sirtuin function”
Quote in the paperSubstantial claim - Premisecitation
SIRT3 protects against hearing loss in response to intense noise exposure.
“SIRT3 also protects against hearing loss in response to intense noise exposure (Brown et al. 2014).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Brown et al. 2014 source
Not checked in the free run.
- Premisecitation
Loss of SIRT3 function is a potential cause of idiopathic pulmonary arterial hypertension.
“Recent work by the Michelakis’s group has identified loss of SIRT3 function as a potential cause of this disease ((Paulin et al. 2014))”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Paulin et al. 2014 source
Not checked in the free run.
- Premisecitation
SIRT3 is necessary for the protective effect of calorie restriction on age-related hearing loss.
“Remarkably, SIRT3 is necessary for the protective effect of calorie restriction on age-related hearing loss supporting a key role for SIRT3-dependent mitochondrial adaptations against aging in mammals (Someya et al. 2010).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Someya et al. 2010 source
Not checked in the free run.
- Premisecitation
SIRT3 and SIRT5 reduce the senescence-associated secretory phenotype, partly by preventing harmful declines in NAD+/NADH ratios.
“Recent work shows that SIRT3 and SIRT5 attenuate the SASP, in part by preventing dysfunctional decreases in NAD+/NADH ratios ((Wiley et al. 2016)).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Wiley et al. 2016 source
Not checked in the free run.
- Interpretationreasoning
If these modifications do not confer new function or activate enzymes, then inhibition through acetylation at roughly 1% occupancy is probably not physiologically relevant.
“Unless these modifications impart new function or activate enzymes, inhibition by acetylation at a level of 1% seems unlikely to be relevant in vivo.”
Quote in the paperSubstantial claim - Premisenone given
In other cell types, SIRT3 loss leads to mitochondrial depolarization via defective oxidative phosphorylation and downstream NAD+ production.
“In other cell types, loss of SIRT3 function leads to mitochondrial depolarization via impaired oxidative phosphorylation and subsequent NAD+ synthesis.”
Quote in the paperNot a substantial claim - Premisecitation
During aging, CD38 promotes mitochondrial dysfunction partly by impairing SIRT3's control of mitochondrial hyperacetylation.
“the NAD-destroying enzyme CD38 was shown to induce mitochondrial dysfunction during aging in part by limiting SIRT3’s ability to control mitochondrial hyperacetylation ((Camacho-Pereira et al. 2016)).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Camacho-Pereira et al. 2016 source
Not checked in the free run.
- Premisecitation
NAD+ supplementation via its precursors nicotinamide riboside and nicotinamide mononucleotide enhances SIRT3 function in tissues such as skeletal muscle.
“Recently, NAD+ supplementation via its precursors nicotinamide riboside and nicotinamide mononucleotide has been shown to enhance SIRT3 function in tissues such as skeletal muscle ((Canto et al. 2012));”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Canto et al. 2012 source
Not checked in the free run.
- Premisecitation
Tissue-specific knockdown of SIRT3 in liver or skeletal muscle does not recapitulate the metabolic alterations despite similar patterns of hyperacetylation in C57Black6 mice.
“However, tissue-specific knockdown of SIRT3 in liver or skeletal muscle does not recapitulate these metabolic alterations, despite similar patterns of hyperacetylation in C57Black6 mice ((Fernandez-Marcos et al. 2012)).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Fernandez-Marcos et al. 2012 source
Not checked in the free run.
- Premisecitation
The dosage scheme used in that study was insufficient to induce deacetylation in neurons.
“the dosage scheme used in this study was insufficient to induce deacetylation in neurons, but longer-term or higher-dose administration may yet offer the best path towards assisting SIRT3 in neuronal deacetylation.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Canto et al. 2012 source
Not checked in the free run.
- Interpretationreasoning
Sirtuins' ability to forestall disease states makes their function key to maximizing healthy lifespan.
“their ability to forestall disease states makes their function key to maximizing healthy lifespan.”
Quote in the paperSubstantial claim - Interpretationreasoning
The low average occupancy of mitochondrial acetylation sites raises significant concerns about the functional relevance of acetylation in biological systems.
“This result raises significant concerns regarding the functional relevance of acetylation in biological systems.”
Quote in the paperSubstantial claim - Premisecitation
SIRT3 plays a key role in adaptive responses to stress.
“This fits with the larger paradigm of SIRT3 playing a key role in adaptive responses to stress ((Cheng et al. 2016))”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Cheng et al. 2016 source
Not checked in the free run.
- Premisecitation
Increasing NAD+ by exogenous supplementation can protect against obesity in part by limiting mitochondrial acylation.
“As already described, increasing NAD+ by exogenous supplementation can protect against obesity ((Canto et al. 2012)) in part by limiting mitochondrial acylation - but can mitochondrial acylation actually cause the disease symptoms associated with excess calorie intake?”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Canto et al. 2012 source
Not checked in the free run.
- Premisecitation
SIRT3 knockout mice exhibit metabolic changes similar to those observed in human metabolic syndrome.
“SIRT3 knockout mice exhibit metabolic changes similar to those observed in the human metabolic syndrome ((Hirschey et al. 2011);(Jing et al. 2013)), and a human SIRT3 polymorphism associated with reduced SIRT3 deacetylase activity is associated with increased risk of metabolic syndrome in humans ((Hirschey et al. 2011).”
Quote in the paperSubstantial claim0 of 2 sources checked - Premisereasoning
Sirtuins protect against multiple aging-associated diseases.
“sirtuins’ role in protecting against multiple aging-associated diseases places them squarely as “anti-aging” proteins”
Quote in the paperNot a substantial claim - Premisecitation
Chemical labeling approaches, apart from the SILAC-based indirect method that overestimates due to cross-talk with other lysine modifications, indicate that average occupancy of most mitochondrial acetylation sites is below 1%.
“With the exception of the SILAC-based indirect stoichiometry method (which overestimates stoichiometry via crosstalk with other lysine modifications), all the chemical labeling methods have concluded that most of the mitochondrial protein acetylation sites are occupied at less than 1% on average.”
Quote in the paperSubstantial claim0 of 3 sources checked - Premisecitation
Many protective features of the calorie-restriction response, including resistance to oxidative stress and reduced hearing loss, require SIRT3.
“SIRT3 is required for many protective aspects of this adaptive shift ((Someya et al. 2010); (Qiu et al. 2010); (Amigo et al. 2017)), such as oxidative stress resistance and attenuated hearing loss.”
Quote in the paperSubstantial claim0 of 3 sources checked - Premisecitation
A SIRT3 polymorphism previously linked to metabolic syndrome was identified in a cohort of 162 patients and controls.
“via identification of a SIRT3 polymorphism previously associated with metabolic syndrome ((Hirschey et al. 2011) in a cohort of 162 patients and controls.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Hirschey et al. 2011 source
Not checked in the free run.
- Premisecitation
A recent study showed that thiols can undergo spontaneous acetylation, providing a route to lysine modification.
“A recent study demonstrated spontaneous acetylation of thiols as a pathway towards lysine modification ((James et al. 2017)).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites James et al. 2017 source
Not checked in the free run.
- May combine two claims. 60
- Classified as probably not a substantial claim. 6
May combine two claims.
PremisecitationSIRT4 can regulate lipoyl- and biotinyl-lysine modifications and demethylglutarylate branched-chain acyl-lysines.
“One study has shown that SIRT4 can regulate the levels of both lipoyl- and biotinyl-lysine modifications in pyruvate dehydrogenase and likely other proteins ((Mathias et al. 2014)).”
- Also stated in: § The Emerging Targets of SIRT4 · plain
“Recombinant SIRT4 was sufficient to demethylglutarylate lysine residues, and SIRT4-overexpressing cells contained lower levels of these branched-chain acyl-lysines.”
Quote in the paperSubstantial claim0 of 2 sources checked- Also stated in: § The Emerging Targets of SIRT4 · plain
May combine two claims.
Interpretationnone givenMitochondrial acylation is mostly non-enzymatic, while nuclear acylation is controlled by competing enzymatic acyltransferases and deacylases.
“While nuclear protein acylation reflects the competing activities of enzymatic acyltransferases and deacylases, mitochondrial acylation appears to be driven mostly via a non-enzymatic mechanism.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationSIRT5 regulates lysine succinylation, malonylation, and glutarylation.
“This work resulted in the identification of novel modifications targeted by SIRT5: succinylation, malonylation and glutarylation as described in details below ((Du et al. 2011{Zhang, 2011 #16);(Peng et al. 2011);(Tan et al. 2014)}.”
Quote in the paperSubstantial claim0 of 3 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing).
InterpretationreasoningA semi-enzymatic mechanism may account for increased acetylation of PDP1 and PDHA1.
“Assuming that ACAT1 is capable of holding a reactive acetyl-CoA molecule in place for long enough, increasing the local concentration of reactive thioester, a semi-enzymatic mechanism may account for increased acetylation to PDP1/PDHA1.”
Quote in the paperNot a substantial claim- The authors state this as an assumption: ACAT1 can hold a reactive acetyl-CoA molecule in place long enough to increase the local concentration of reactive thioester, enabling a semi-enzymatic mechanism for increased acetylation of PDP1 and PDHA1.
May combine two claims.
PremisecitationGCN5L1 interacts with and promotes acetylation of respiratory chain proteins and reverses global SIRT3 effects on mitochondrial acetylation, respiration, and bioenergetics.
“GCN5L1 interacts with and promotes acetylation respiratory chain target proteins and reverses global SIRT3 effects on mitochondrial protein acetylation, respiration and bioenergetics ((Scott et al. 2012)).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Scott et al. 2012 source
Not checked in the free run.
May combine two claims.
Premisenone givenProteomic surveys have identified mitochondrial acetylation, succinylation, glutarylation, and malonylation sites and their regulation by SIRT3 and SIRT5.
“Recent proteomic surveys of mitochondrial protein acylation have identified the sites of protein acetylation, succinylation, glutarylation and malonylation and their regulation by SIRT3 and SIRT5.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationDenatured proteins are more rapidly acetylated by coincubation with acetyl-CoA, indicating that local structure slows acylation.
“For example, denatured proteins are more rapidly acetylated by coincubation with acetyl-CoA (Wagner and Payne 2013), indicating that local structure slows acylation; past studies have shown that sirtuins favor either unstructured regions (Khan and Lewis 2005, Smith et al. 2011) or, in the case of SIRT3, beta sheets (Smith et al. 2011).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Wagner and Payne 2013
Not checked in the free run.
May combine two claims.
Interpretationnone givenDietary inputs and tissue metabolic demands create acyl-CoA concentrations that interact with mitochondrial molecular context to drive acylation at different rates, and sirtuin expression and NAD+ supply reverse this process.
“Broadly, dietary inputs and the metabolic demands of various tissues create acyl-CoA concentrations with interact with molecular contexts in mitochondria to drive acylation at differing rates for different targets; gene expression of and NAD+ supply to sirtuins then reverses this process.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationVDACs are outer mitochondrial membrane proteins with tissue-dependent expression and are part of the acylcarnitine translocase pathway.
“Voltage-dependent anion channels (VDACs) are outer mitochondrial membrane proteins with tissue-dependent expression patterns and are part of the acylcarnitine translocase pathway ((Lee, Kerner, and Hoppel 2011)); their partners on the inner membrane, adenine nucleotide translocases (ANTs), are known to be acetylated and some sites are predicted to be functionally important to channel function (Mie”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Lee, Kerner, and Hoppel 2011 source
Not checked in the free run.
May combine two claims.
PremisecitationMice with SCAD deficiency accumulate high levels of butyryl-CoA and show increased protein lysine butyrylation.
“Mice with short-chain acyl-CoA dehydrogenase (SCAD) deficiency accumulate high levels of butyryl-CoA and show increased protein lysine butyrylation ((Pougovkina et al. 2014)).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Pougovkina et al. 2014 source
Not checked in the free run.
May combine two claims.
PremisecitationKnockdown of GCN5L1 reduces mitochondrial protein acetylation, and reconstitution in intact mitochondria restores it.
“Genetic knockdown of GCN5L1 blunts mitochondrial protein acetylation, and its reconstitution in intact mitochondria restores protein acetylation.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Scott et al. 2012 source
Not checked in the free run.
May combine two claims.
PremisecitationProlonged hypernutrition leads to type 2 diabetes and impairs skeletal muscle glucose uptake.
“However, prolonged hypernutrition leads to type 2 diabetes, and has been shown to impair skeletal muscle glucose uptake in a manner exacerbated by the loss of SIRT3 (Jing et al. 2013),(Lantier et al. 2015).”
Quote in the paperNot a substantial claim0 of 2 sources checkedMay combine two claims.
PremisecitationCalorie restriction does not change brain mitochondrial acetylation and decreases skeletal muscle acetylation.
“Metabolic supplier organs such as the liver and kidney demonstrate mitochondrial hyperacetylation under CR, as does the heart (Schwer et al. 2009); brain mitochondrial acetylation was unchanged, however, and skeletal muscle acetylation decreased.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Schwer et al. 2009 source
Not checked in the free run.
May combine two claims.
PremisecitationLoss of SIRT3 decreases gluconeogenic glucose production after cold challenge and decreases beta-hydroxybutyrate production during fasting.
“Loss of SIRT3 has been shown to inhibit fatty acid oxidation ((Hirschey et al. 2010)); the same study showed decreased gluconeogenic production of glucose in response to cold challenge and decreased production of the ketone body beta-hydroxybutyrate during fasting.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Hirschey et al. 2010 source
Not checked in the free run.
May combine two claims.
PremisecitationDuring calorie restriction, liver mitochondrial proteins show an overall increase in acetylation, while proteins in other cellular compartments do not.
“Proteomic characterization of the changes in liver reveals a complicated landscape of alterations, but an overall increase in acetylation levels for mitochondrial proteins but not those found in other cellular compartments during CR (Hebert et al. 2013).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Hebert et al. 2013 source
Not checked in the free run.
May combine two claims.
PremisecitationANTs are known to be acetylated, and some acetylation sites are predicted to be functionally important for channel function.
“their partners on the inner membrane, adenine nucleotide translocases (ANTs), are known to be acetylated and some sites are predicted to be functionally important to channel function (Mielke et al. 2014).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Mielke et al. 2014 source
Not checked in the free run.
May combine two claims.
PremisecitationSirtuins favor unstructured regions, and SIRT3 favors beta sheets.
“past studies have shown that sirtuins favor either unstructured regions (Khan and Lewis 2005, Smith et al. 2011) or, in the case of SIRT3, beta sheets (Smith et al. 2011).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Khan and Lewis 2005
Not checked in the free run.
- cites Smith et al. 2011 source
Not checked in the free run.
May combine two claims.
InterpretationreasoningEvidence such as the link to MnSOD supports roles for acylation both as a direct effector modulated by NAD+ and in transducing NAD+ into an N-methylnicotinamide signal.
“As NAD+ supplementation also results in potentially beneficial production of N-methylnicotinamide via sirtuins ((Schmeisser et al. 2013)), evidence such as the link to MnSOD affirms roles for acylation both as a direct effector modulated by NAD+ and in transducing NAD+ into an N-methylnicotinamide signal.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationSIRT3 deacetylates PDP, enhancing its phosphatase activity on PDC and decreasing PDC phosphorylation.
“First, SIRT3 deacetylates K321 and second, SIRT3 also deacetylates PDP, enhancing its phosphatase activity on PDC and thereby decreasing PDC phosphorylation. ((Fan et al. 2014)).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Fan et al. 2014 source
Not checked in the free run.
May combine two claims.
PremisecitationLipoylation occurs at two sites in the E2 N-terminal region, K132 and K259 in the human sequence, and is enzymatically reversed by SIRT4.
“Lipoylation occurs at two sites in the E2 N-terminal region (K132 and K259 in the human sequence), and is enzymatically reversed by SIRT4 ((Mathias et al. 2014)).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Mathias et al. 2014 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based). May combine two claims.
InterpretationreasoningThe effect of SIRT5-mediated removal of PDC succinylation is not known but would be expected to activate the enzyme similarly to SIRT3.
“The effect of SIRT5-mediated removal of PDC succinylation is not known but would be expected to activate the enzyme similar to SIRT3.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationAcetylation of PDHA1 K321 recruits PDK, leading to PDC phosphorylation and inhibition of its enzymatic activity.
“Acetylation of PDHA1 K321 recruits PDK leading to PDC phosphorylation and inhibition of its enzymatic activity.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Jing et al. 2013 source
Not checked in the free run.
May combine two claims.
PremisecitationThe protective effects of nicotinamide riboside on noise-induced hearing loss appear to be mediated in mitochondria because SIRT3-overexpressing mice are resistant and SIRT3 deletion abrogates the protection.
“These effects appear to be mediated in the mitochondria because SIRT3-overexpressing mice are resistant to noise-induced hearing loss and SIRT3 deletion abrogates the protective effects of nicotinamide riboside ((Brown et al. 2014))”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Brown et al. 2014 source
Not checked in the free run.
May combine two claims.
PremisecitationLysine succinylation has been observed on DLAT, DLD, and PDHA1, including multiple succinylations controlled by SIRT5.
“Lysine succinylation has been observed on DLAT in addition to DLD and PDHA1, including multiple succinylations controlled by SIRT5 ((Rardin, He, et al. 2013)).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Rardin, He, et al. 2013
Not checked in the free run.
May combine two claims.
InterpretationreasoningSIRT3 facilitates fatty acid catabolism in the liver and the peripheral use of lipid-derived acetate and ketone bodies during fasting.
“SIRT3 therefore facilitates the catabolism of fatty acids in the liver and the peripheral use of lipid-derived acetate and ketone bodies during fasting.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningLysine residues near arginine may have decreased pKa and be more likely to be uncharged, leaving their free electron pair available for acylation.
“For example, lysine residues near arginine may have decreased pKa and be more likely to have no charge, leaving their free electron pair available for acylation.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningSIRT3 and SIRT4 regulate the PDC in opposing directions: SIRT3 clearance of lysine acetylation allows efficient PDC function, while SIRT4 removal of enzymatically active cofactors from specific lysine residues inhibits the PDC.
“Thus, SIRT3 and SIRT4 regulate the PDC in opposing directions; SIRT3’s clearance of lysine acetylation allows for efficient PDC function, while SIRT4’s removal of enzymatically active cofactors from specific lysine residues inhibits the PDC.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationAdministering the NAD precursor nicotinamide riboside prevents noise-induced hearing loss and degeneration of spiral ganglia neurites.
“Administering the NAD precursor nicotinamide riboside prevents noise-induced hearing loss and degeneration of spiral ganglia neurite degeneration.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Brown et al. 2014 source
Not checked in the free run.
May combine two claims.
PremisecitationSIRT3 and SIRT5 both positively regulate HMGCS2 activity via deacetylation and desuccinylation, respectively.
“SIRT3 and SIRT5 both positively regulate HMGCS2 activity via respectively deacetylating and desuccinylating it ((Shimazu et al. 2010))((Rardin, He, et al. 2013)).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Shimazu et al. 2010 source
Not checked in the free run.
- cites Rardin, He, et al. 2013
Not checked in the free run.
May combine two claims.
PremisecitationMice lacking SIRT5 fail to upregulate CPS1 activity and show elevated blood ammonia under fasting, calorie restriction, or high protein diet.
“Mice lacking SIRT5 fail to upregulate CPS1 activity and show elevated blood ammonia under these conditions ((Nakagawa et al. 2009))((Tan et al. 2014)).”
Quote in the paperSubstantial claim0 of 2 sources checkedMay combine two claims.
PremisecitationCPS1 has at least 52 acetylated, 44 succinylated, 33 glutarylated, and 29 malonylated lysine sites.
“At least 52 lysine sites are found to be acetylated, 44 sites succinylated, 33 sites glutarylated and 29 sites malonylated.”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites Nakagawa et al. 2009 source
Not checked in the free run.
- cites Rardin, Newman, et al. 2013
Not checked in the free run.
- cites Rardin, He, et al. 2013
Not checked in the free run.
May combine two claims.
InterpretationcitationCPS1 and OTC carry out the first two steps of the urea cycle and are both regulated by mitochondrial sirtuins.
“The two mitochondrial enzymes, carbamoyl phosphate synthetase 1 (CPS1) and Ornithine transcarbamylase (OTC), which carry out the first two steps of urea cycle reactions, are both regulated by the activities of mitochondrial sirtuins.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationCalorie restriction stimulates the urea cycle and upregulates OTC activity; this upregulation is lost in the absence of SIRT3, leading to increased orotic acid levels.
“Calorie restriction stimulates the urea cycle and up-regulates OTC activity; this up-regulation of OTC activity is lost in the absence of SIRT3, leading to increased orotic acid levels, a known outcome of OTC deficiency ((Hallows et al. 2011)).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Hallows et al. 2011 source
Not checked in the free run.
May combine two claims.
InterpretationreasoningSIRT5 restores the positively charged microenvironment of HMGCS2 and facilitates enzymatic function by removing succinyl groups.
“SIRT5, by removing these succinyl groups, restores the positively charged microenvironment and facilitates enzymatic function.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationBeta-hydroxybutyrate is an endogenous inhibitor of HDACs and can affect gene expression via chromatin modifications and regulate the response to oxidative stress.
“Beta-hydroxybutyrate is an endogenous inhibitor of HDACs and can thereby affect gene expression via chromatin modifications and regulate the response to oxidative stress ((Shimazu et al. 2013)).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Shimazu et al. 2013 source
Not checked in the free run.
May combine two claims.
PremisecitationIn silico deacetylation of HMGCS2 lysines 310, 447, and 473 causes conformational changes near the catalytic site, suggesting acetylation might interfere with enzymatic activity via changing conformation.
“Structural simulations show that in silico deacetylation of these three lysines causes conformational changes of HMGCS2 near the catalytic site, suggesting acetylation might interfere with the enzymatic activity via changing its conformation ((Shimazu et al. 2010)).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Shimazu et al. 2010 source
Not checked in the free run.
May combine two claims.
InterpretationreasoningSuccinylation of HMGCS2 K83 and K310 may disrupt the positively charged microenvironment and reduce enzymatic activity.
“This highly positive microenvironment might be disrupted when the two lysines are modified by negatively charged succinyl groups leading to a reduction in enzymatic activity.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationMice lacking SIRT3 or SIRT5 have reduced levels of ketone bodies upon fasting, supporting a positive role for sirtuins in regulating ketone body biosynthesis.
“Mice lacking SIRT3 or SIRT5 have reduced levels of ketone bodies upon fasting, supporting a positive role for sirtuins in regulating ketone body biosynthesis ((Shimazu et al. 2010))((Rardin, He, et al. 2013)).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Shimazu et al. 2010 source
Not checked in the free run.
- cites Rardin, He, et al. 2013
Not checked in the free run.
May combine two claims.
PremisecitationThe three cytosolic urea cycle enzymes are malonylated at multiple sites and demalonylated at some sites by SIRT5.
“The three other enzymes in the urea cycle are located in the cytosol and are also malonylated at multiple sites with demalonylation at some sites by SIRT5 (Nishida et al. 2015).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Nishida et al. 2015 source
Not checked in the free run.
May combine two claims.
PremisereasoningCPS1 is the most heavily modified protein in mitochondria, possibly due to its high abundance and relatively large size.
“CPS1 is the most heavily modified protein in mitochondria, possibly due to its high abundance and relatively large size.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationSIRT3 deacetylates manganese superoxide dismutase and isocitrate dehydrogenase 2.
“The mitochondrial SIRT3 deacetylates two of these enzymes: manganese superoxide dismutase (MnSOD) (Tao et al. 2010) and isocitrate dehydrogenase 2 (IDH2)(Someya et al. 2010).”
Quote in the paperSubstantial claim0 of 2 sources checkedMay combine two claims.
PremisecitationSIRT3 attenuates cell death after excitotoxic stress and mediates the protective effect of exercise against such stress, possibly via deacetylation of cyclophilin D.
“Similarly, SIRT3 function has been shown to attenuate cell death after excitotoxic stress, and mediates the protective effect of exercise against such stress ((Cheng et al. 2016)), possibly via deacetylation of cyclophilin D ((Cheng et al. 2016),(Amigo et al. 2017)).”
Quote in the paperNot a substantial claim0 of 2 sources checkedMay combine two claims.
PremisecitationBoth MnSOD and the various mitochondrial superoxide sources are acylated.
“Both MnSOD and the various mitochondrial superoxide sources are acylated ((Rardin, Newman, et al. 2013), (Rardin, He, et al. 2013);(Tan et al. 2014)); MnSOD also carries glutarylation, succinylation, and acetylation at functionally required lysine residues near its active site, K122 in particular bears all three modifications ((Tao et al. 2010)).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites Rardin, Newman, et al. 2013
Not checked in the free run.
- cites Rardin, He, et al. 2013
Not checked in the free run.
- cites Tan et al. 2014 source
Not checked in the free run.
May combine two claims.
InterpretationreasoningSIRT4 control of tumorigenesis is particularly relevant to c-Myc-driven, mitochondrially active, glutamine-dependent tumors, while SIRT3 prevents less mitochondrially active tumors.
“SIRT4 control of tumorigenesis is therefore particularly relevant to c-Myc-driven, mitochondrially active, glutamine-dependent tumors, while SIRT3 prevents less mitochondrially active tumors.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationGLUD1 is inhibited by SIRT4 and by acetylation that can be reversed by SIRT3.
“GLUD1 is inhibited by SIRT4 ((Haigis et al. 2006)) and by acetylation which can be reversed by SIRT3 ((Schlicker et al. 2008)).”
Quote in the paperNot a substantial claim0 of 2 sources checkedMay combine two claims.
PremisecitationOxidized glutathione underpins all mitochondrial H2O2 detoxification and is reduced by NADPH-dependent glutathione reductases.
“Oxidized glutathione thus underpins all mitochondrial H2O2 detoxification, and is reduced by NADPH-dependent glutathione reductases ((Merksamer et al. 2013)).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Merksamer et al. 2013 source
Not checked in the free run.
May combine two claims.
InterpretationreasoningMitochondrial acylation can modulate neuronal function, and its removal by sirtuins can help improve health.
“Given the effects already demonstrated of mitochondrial acylation in allowing tumorigenesis and increasing production of reactive oxygen species, it should come as no surprise that mitochondrial acylation can modulate neuronal function - and, more interestingly, that its removal by sirtuins can help improve health.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationIDH2 function is inhibited by acetylation, and its deacetylation by SIRT3 restores function.
“IDH2 function is inhibited by acetylation, and its deacetylation by SIRT3 restores function ((Schlicker et al. 2008)).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Schlicker et al. 2008 source
Not checked in the free run.
May combine two claims.
PremisecitationASSY is demalonylated by SIRT5 at 2 of 11, ARLY at 1 of 6, and ARG1 at 3 of 16 malonyllysine sites.
“These are argininosuccinate synthase (ASSY), argininosuccinate lyase (ARLY), and arginase (ARGI1); ASSY is demalonylated by SIRT5 at 2 of 11, ARLY at 1 of 6, and ARG1 at 3 of 16 malonyllysine sites.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Nishida et al. 2015 source
Not checked in the free run.
May combine two claims.
PremisecitationSIRT3 has been reported as pro-apoptotic, and SIRT3 loss is associated with a tumor-permissive environment via inhibition of ROS production.
“SIRT3 has been reported as pro-apoptotic ((Allison and Milner 2007)) and SIRT3 loss is associated with a tumor-permissive environment via the inhibition of ROS production ((Kim et al. 2010);(Bell et al. 2011);(Finley et al. 2011)).”
Quote in the paperNot a substantial claim0 of 3 sources checkedMay combine two claims.
PremisecitationMnSOD carries glutarylation, succinylation, and acetylation at functionally required lysine residues near its active site, with K122 bearing all three modifications.
“MnSOD also carries glutarylation, succinylation, and acetylation at functionally required lysine residues near its active site, K122 in particular bears all three modifications ((Tao et al. 2010)).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Tao et al. 2010 source
Not checked in the free run.
May combine two claims.
InterpretationreasoningIDH2 competes with NAD+-dependent IDH3 for isocitrate, so tuning IDH2 activity regulates available NADPH for H2O2 detoxification.
“IDH2 competes with NAD+-dependent IDH3 for isocitrate; tuning the activity of IDH2 thus regulates available NADPH for H2O2 detoxification.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationThiol groups can mediate nucleophilic attack at least as well as deprotonated amines and are abundant in the mitochondrial matrix.
“thiol residues are as capable as deprotonated amines of mediating nucleophilic attack, if not more so, and are found in large numbers in the mitochondrial matrix ((Requejo et al. 2010)).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Requejo et al. 2010 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
InterpretationreasoningSince pathway-wide acylation is frequently observed, biological effects might arise from the combined action of many modifications each at low occupancy.
“Given that studies often find pathway-wide acylation, it may be that the cumulative effect of dozens of low-occupancy modifications mediates biological effects.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningReduced SIRT3 activity narrows mitochondrial functional capacity in several ways, and the specific failure mode in any disease depends on which linked mitochondrial pathway is most burdened and therefore most vulnerable to hyperacetylation.
“Loss of SIRT3 activity thus limits the functional envelope of mitochondria in multiple directions, with the precise failure mechanism for a given disease depending on which of many connected mitochondrial pathways is most taxed and thus most sensitive to hyperacetylation.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningSIRT3 opposes aging both by reducing systemic stressors like NAD+ decline and by improving the ability to withstand the damage they cause.
“SIRT3 thus fights aging by attenuating the development of systemic stressors such as NAD+ loss and by enhancing our ability to survive the resulting insults.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationThe V208I mutation increases the KM of SIRT3 for NAD+ and reduces the Vmax toward peptide substrate, reducing catalytic efficiency and creating a ~1.4-fold increase in risk for metabolic syndrome.
“The V208I mutation caused by this polymorphism both increased the KM of SIRT3 for NAD+ and reduced the Vmax of the enzyme towards peptide substrate, reducing overall catalytic efficiency and mimicking the effects of reduced SIRT3 expression at the whole-body level and creating a ~1.4-fold increase in risk for metabolic syndrome ((Hirschey et al. 2011)).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Hirschey et al. 2011 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Interpretationnone givenSirtuins may not alter the overall rate of organismal aging.
“while sirtuins may not alter the overall rate of organismal aging”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationThe protective effects of nicotinamide riboside against noise-induced hearing loss depend on SIRT3, since SIRT3 overexpression confers resistance and SIRT3 deletion abrogates protection.
“These effects are dependent on SIRT3, since SIRT3-overexpressing mice are resistant to noise-induced hearing loss and SIRT3 deletion abrogates the protective effects of NR.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Brown et al. 2014 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
InterpretationcitationCurrent research argues both for and against a causative role for mitochondrial protein acylation in metabolic disorders.
“Current research argues both for and against a causative role for mitochondrial protein acylation in metabolic disorders.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S4 (based).
Interpretationnone givenHypernutrition and its associated disease states are characterized by increased availability of acyl-CoA precursors believed to drive the bulk of mitochondrial acylation.
“Hypernutrition and its associated disease states, such as obesity and type 2 diabetes, are characterized by an increased availability of the acyl-CoA precursors which are believed to drive the bulk of mitochondrial acylation.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationCochlear NAD+ levels increased in mice after administering nicotinamide riboside and prevented noise-induced hearing loss.
“Cochlear NAD(+) levels increased in mice after administering nicotinamide riboside, a precursor to NAD(+) and prevented noise-induced hearing loss.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Brown et al. 2014 source
Not checked in the free run.
May combine two claims.
InterpretationreasoningWith age, CD38 lowers NAD+, raising inflammatory SASP cytokines that drive proliferation of cells expressing CD38; SIRT3 restrains this cycle by lessening the associated mitochondrial dysfunction.
“The CD38-induced loss of NAD+ with age thus leads to increases in inflammatory SASP cytokines, which in turn lead to proliferation of CD38-expressing cells; SIRT3 function, by attenuating the resulting loss of mitochondrial function, helps keep this loop in check.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationIn diseased smooth muscle, hyperacetylation of mitochondrial proteins drives mitochondrial hyperpolarization, greater proliferation, reduced apoptosis, and eventual arterial wall thickening.
“Increased acetylation of mitochondrial proteins in the affected smooth muscle leads to mitochondrial hyperpolarization, increased proliferation, suppressed apoptosis, and eventually to progressive arterial thickening.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Paulin et al. 2014 source
Not checked in the free run.
May combine two claims.
InterpretationreasoningA single SIRT3 polymorphism may produce harmful overactivity in arterial cells while causing harmful underactivity in metabolic pathways.
“the same polymorphism can lead to pathological gain of function in arterial cells and pathological loss of function in metabolism.”
Quote in the paperSubstantial claim
The authors state this as an assumption.
ACAT1 can hold a reactive acetyl-CoA molecule in place long enough to increase the local concentration of reactive thioester, enabling a semi-enzymatic mechanism for increased acetylation of PDP1 and PDHA1.
“Assuming that ACAT1 is capable of holding a reactive acetyl-CoA molecule in place for long enough, increasing the local concentration of reactive thioester, a semi-enzymatic mechanism may account for increased acetylation to PDP1/PDHA1.”
The paper relies on this without support.
Mitochondrial acylation sites generally have low stoichiometry.
“Given the generally low stoichiometry of mitochondrial acylation sites, each disease is likely mediated by multiple presently-unidentified acylations, each slightly but cooperatively impairing mitochondrial function.”
The paper relies on this without support.
Both over-nutrition and under-nutrition create abnormal metabolic states with high levels of acyl-CoAs.
“Both over- and under-nutrition create abnormal metabolic states with high levels of acyl-CoAs.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Sirtuins regulate key metabolic processes, stress responses and ageing biology.
“Since their discovery, the sirtuins have received much attention because they regulate key metabolic processes, stress responses and ageing biology7.”
From NAD+ metabolism and its roles in cellular processes during ageing (2021) · cites this paper as [7]
Nuclear SIRT1, SIRT6 and SIRT7 are critical regulators of DNA repair and genome stability, and mitochondrial SIRT3, SIRT4 and SIRT5 and nuclear SIRT1 regulate mitochondrial homeostasis and metabolism.
“Specifically, recent evidence has shown that nuclear SIRT1, SIRT6 and SIRT7 are critical regulators of DNA repair and genome stability and that mitochondrial SIRT3, SIRT4 and SIRT5 and nuclear SIRT1 regulate mitochondrial homeostasis and metabolism7.”
From NAD+ metabolism and its roles in cellular processes during ageing (2021) · cites this paper as [7]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Incorrect percentage of SIRT5-regulated malonylation sites
MinorThe reported 183 sites are about 16.1% of the 1,137 sites identified, not 13%.
Reported 13 · recomputed 16.094987
“identified 1137 unique malonylation sites in 430 total proteins of which 183 sites (13%) were increased”
Five-tissue quantification conflicts with the reported overlap
MinorIf 80% of the 6,286 sites were quantified in all five tissues, more than 5,000 sites would be shared across them. The passage instead reports only 87 shared sites.
“Overall, they identified 6286 sites of acetylation, quantified the abundance of 80% of these sites in all five tissues”
“found a relatively small set of 87 shared sites, with a much larger number of sites unique to each tissue”
Opposite claims about SIRT3 loss and ROS production
MinorThe cancer section attributes an effect of SIRT3 loss to inhibited ROS production, but elsewhere says SIRT3 itself attenuates ROS production. These assign opposite directions to the effect of losing SIRT3.
“SIRT3 loss is associated with a tumor-permissive environment via the inhibition of ROS production”
“SIRT3’s attenuation of reactive oxygen species production appears to inhibit a glycolytic shift in potentially cancerous cells”
Conflicting claims about functional PDHA1 acetylation sites
MinorOne passage says acetylation at K336 inhibits pyruvate dehydrogenase activity; another says a functional role has been demonstrated only for acetylation at K321.
“including acetylation of K336 in PDH E1alpha subunit leading to inhibition of pyruvate dehydrogenase activity.”
“a functional role for acetylation has only been demonstrated for modification of lysine 321 of PDHA1”
Cites
Ong, S.-E., Blagoev, B., Kratchmarova, I., Kristensen, D. B., Steen, H., Pandey, A., & Mann, M. (2002) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m200025-mcp200 · Cited by 5,574 · see citing works
Lysine acetylation targets protein complexes and co-regulates major cellular functions
Choudhary, C., Kumar, C., Gnad, F., Nielsen, M. L., Rehman, M., Walther, T. C., Olsen, J. V., & Mann, M. (2009) · Science · doi:10.1126/science.1175371 · Cited by 4,040 · see citing works
Regulation of cellular metabolism by protein lysine acetylation
Zhao, S., Xu, W., Jiang, W., Yu, W., Lin, Y., Zhang, T., Yao, J., Zhou, L., Zeng, Y., Li, H., et al. (2010) · Science · doi:10.1126/science.1179689 · Cited by 1,910 · see citing works
Suppression of Oxidative Stress by β-Hydroxybutyrate, an Endogenous Histone Deacetylase Inhibitor
Shimazu, T., Hirschey, M. D., Newman, J., He, W., Shirakawa, K., Le Moan, N., Grueter, C. A., Lim, H., Saunders, L. R., Stevens, R. D., et al. (2013) · Science · doi:10.1126/science.1227166 · Cited by 1,777 · see citing works
Self-citationSIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation
Hirschey, M. D., Shimazu, T., Goetzman, E., Jing, E., Schwer, B., Lombard, D. B., Grueter, C. A., Harris, C., Biddinger, S., Ilkayeva, O. R., et al. (2010) · Nature · doi:10.1038/nature08778 · Cited by 1,687 · see citing works
Self-citationQuantitative Phosphoproteomics Reveals Widespread Full Phosphorylation Site Occupancy During Mitosis
Olsen, J., Vermeulen, M., Santamaría, A., Kumar, C., Miller, M. L., Jensen, L., Gnad, F., Cox, J., Jensen, T., Nigg, E., et al. (2010) · Science Signaling · doi:10.1126/scisignal.2000475 · Cited by 1,552 · see citing works
Substrate and Functional Diversity of Lysine Acetylation Revealed by a Proteomics Survey
Kim, S. C., Sprung, R., Chen, Y., Xu, Y., Ball, H., Pei, J., Cheng, T., Kho, Y., Xiao, H., Xiao, L., et al. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.06.026 · Cited by 1,487 · see citing works
Sirt5 Is a NAD-Dependent Protein Lysine Demalonylase and Desuccinylase
Du, J., Zhou, Y., Su, X., Yu, J. J., Khan, S., Jiang, H., Kim, J., Woo, J., Kim, J. H., Choi, B. H., et al. (2011) · Science · doi:10.1126/science.1207861 · Cited by 1,429 · see citing works
Yoshino, J., Mills, K. F., Yoon, M. J., & Imai, S.-I. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.08.014 · Cited by 1,340 · see citing works
The growing landscape of lysine acetylation links metabolism and cell signalling
Choudhary, C., Weinert, B. T., Nishida, Y., Verdin, E., & Mann, M. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3841 · Cited by 1,324 · see citing works
Self-citationCalorie restriction reduces oxidative stress by SIRT3-mediated SOD2 activation
Qiu, X., Brown, K., Hirschey, M. D., Verdin, E., & Chen, D. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.11.015 · Cited by 1,310 · see citing works
Self-citationMitochondrial Dysfunction Induces Senescence with a Distinct Secretory Phenotype
Wiley, C. D., Velarde, M. C., Lecot, P., Liu, S., Sarnoski, E. A., Freund, A., Shirakawa, K., Lim, H. W., Davis, S. S., Ramanathan, A., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2015.11.011 · Cited by 1,275 · see citing works
Self-citationMcAlister, G. C., Nusinow, D. P., Jedrychowski, M. P., Wühr, M., Huttlin, E. L., Erickson, B. K., Rad, R., Haas, W., & Gygi, S. P. (2014) · Analytical Chemistry · doi:10.1021/ac502040v · Cited by 1,263 · see citing works
Cantó, C., Houtkooper, R. H., Pirinen, E., Youn, D. Y., Oosterveer, M. H., Cen, Y., Fernandez-Marcos, P. J., Yamamoto, H., Andreux, P. A., Cettour-Rose, P., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.04.022 · Cited by 1,238 · see citing works
Mammalian Sir2 homolog SIRT3 regulates global mitochondrial lysine acetylation
Lombard, D. B., Alt, F. W., Cheng, H.-L., Bunkenborg, J., Streeper, R. S., Mostoslavsky, R., Kim, J., Yancopoulos, G., Valenzuela, D., Murphy, A., et al. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01636-07 · Cited by 1,216 · see citing works
Self-citationMouchiroud, L., Houtkooper, R. H., Moullan, N., Katsyuba, E., Ryu, D., Cantó, C., Mottis, A., Jo, Y.-S., Viswanathan, M., Schoonjans, K., et al. (2013) · Cell · doi:10.1016/j.cell.2013.06.016 · Cited by 1,210 · see citing works
Haigis, M. C., Mostoslavsky, R., Haigis, K. M., Fahie, K., Christodoulou, D. C., Murphy, A. J., Valenzuela, D. M., Yancopoulos, G. D., Karow, M., Blander, G., et al. (2006) · Cell · doi:10.1016/j.cell.2006.06.057 · Cited by 1,162 · see citing works
Someya, S., Yu, W., Hallows, W. C., Xu, J., Vann, J. M., Leeuwenburgh, C., Tanokura, M., Denu, J. M., & Prolla, T. A. (2010) · Cell · doi:10.1016/j.cell.2010.10.002 · Cited by 1,150 · see citing works
Identification of lysine succinylation as a new post-translational modification
Zhang, Z., Tan, M., Xie, Z., Dai, L., Chen, Y., & Zhao, Y. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.495 · Cited by 1,027 · see citing works
SIRT5-mediated lysine desuccinylation impacts diverse metabolic pathways
Park, J., Chen, Y., Tishkoff, D. X., Peng, C., Tan, M., Dai, L., Xie, Z., Zhang, Y., Zwaans, B. M. M., Skinner, M. E., et al. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.06.001 · Cited by 1,000 · see citing works
Ketone bodies as signaling metabolites
Newman, J. C., & Verdin, E. (2014) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2013.09.002 · Cited by 966 · see citing works
Self-citationCamacho-Pereira, J., Tarragó, M. G., Chini, C. C. S., Nin, V., Escande, C., Warner, G. M., Puranik, A. S., Schoon, R. A., Reid, J. M., Galina, A., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.05.006 · Cited by 901 · see citing works
Tao, R., Coleman, M. C., Pennington, J. D., Ozden, O., Park, S.-H., Jiang, H., Kim, H.-S., Flynn, C. R., Hill, S., Hayes McDonald, W., et al. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.12.013 · Cited by 899 · see citing works
50 years of protein acetylation: from gene regulation to epigenetics, metabolism and beyond
Verdin, E. M., & Ott, M. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3931 · Cited by 876 · see citing works
Self-citationLysine glutarylation is a protein posttranslational modification regulated by SIRT5
Tan, M., Peng, C., Anderson, K. A., Chhoy, P., Xie, Z., Dai, L., Park, J., Chen, Y., Huang, H., Zhang, Y., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.03.014 · Cited by 844 · see citing works
Quantitative mass spectrometry in proteomics: critical review update from 2007 to the present
Bantscheff, M., Lemeer, S., Savitski, M. M., & Kuster, B. (2012) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-012-6203-4 · Cited by 801 · see citing works
Sirtuins deacetylate and activate mammalian acetyl-CoA synthetases
Hallows, W. C., Lee, S., & Denu, J. M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604392103 · Cited by 792 · see citing works
SIRT5 deacetylates carbamoyl phosphate synthetase 1 and regulates the urea cycle
Nakagawa, T., Lomb, D. J., Haigis, M. C., & Guarente, L. (2009) · Cell · doi:10.1016/j.cell.2009.02.026 · Cited by 787 · see citing works
Hirschey, M. D., Shimazu, T., Jing, E., Grueter, C. A., Collins, A. M., Aouizerat, B., Stančáková, A., Goetzman, E., Lam, M. M., Schwer, B., et al. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.07.019 · Cited by 787 · see citing works
Self-citationKim, H.-S., Patel, K., Muldoon-Jacobs, K., Bisht, K. S., Aykin-Burns, N., Pennington, J. D., van der Meer, R., Nguyen, P., Savage, J., Owens, K. M., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.11.023 · Cited by 785 · see citing works
SIRT3 Opposes Reprogramming of Cancer Cell Metabolism through HIF1α Destabilization
Finley, L. W. S., Carracedo, A., Lee, J., Souza, A., Egia, A., Zhang, J., Teruya-Feldstein, J., Moreira, P. I., Cardoso, S. M., Clish, C. B., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.02.014 · Cited by 782 · see citing works
The first identification of lysine malonylation substrates and its regulatory enzyme
Peng, C., Lu, Z., Xie, Z., Cheng, Z., Chen, Y., Tan, M., Luo, H., Zhang, Y., He, W., Yang, K., et al. (2011) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m111.012658 · Cited by 751 · see citing works
Self-citationKong, X., Wang, R., Xue, Y., Liu, X., Zhang, H., Chen, Y., Fang, F., & Chang, Y. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011707 · Cited by 718 · see citing works
SIRT5 Regulates the Mitochondrial Lysine Succinylome and Metabolic Networks
Rardin, M. J., He, W., Nishida, Y., Newman, J. C., Carrico, C., Danielson, S. R., Guo, A., Gut, P., Sahu, A. K., Li, B., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.11.013 · Cited by 711 · see citing works
Self-citationSchwer, B., Bunkenborg, J., Verdin, R. O., Andersen, J. S., & Verdin, E. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603968103 · Cited by 705 · see citing works
Self-citationFeldman, J. L., Baeza, J., & Denu, J. M. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.c113.511261 · Cited by 637 · cited 2× · see citing works
“Other lysine acylations targeted by sirtuins Evidence is also emerging that most sirtuins may act on multiple acyl substrates, at least in vitro ((Feldman, Baeza, and Denu 2013)).”
BackgroundCalorie restriction and SIRT3 trigger global reprogramming of the mitochondrial protein acetylome
Hebert, A. S., Dittenhafer-Reed, K. E., Yu, W., Bailey, D. J., Selen, E. S., Boersma, M. D., Carson, J. J., Tonelli, M., Balloon, A. J., Higbee, A. J., et al. (2013) · Molecular Cell · doi:10.1016/j.molcel.2012.10.024 · Cited by 636 · see citing works
Schwer, B., North, B. J., Frye, R. A., Ott, M., & Verdin, E. M. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200205057 · Cited by 599 · see citing works
Self-citationThe mTORC1 Pathway Stimulates Glutamine Metabolism and Cell Proliferation by Repressing SIRT4
Csibi, A., Fendt, S.-M., Li, C., Poulogiannis, G., Choo, A. Y., Chapski, D. J., Jeong, S. M., Dempsey, J. M., Parkhitko, A., Morrison, T., et al. (2013) · Cell · doi:10.1016/j.cell.2013.04.023 · Cited by 586 · see citing works
SIRT3, a human SIR2 homologue, is an NAD- dependent deacetylase localized to mitochondria
Onyango, P. O., Celic, I., McCaffery, J. M., Boeke, J. D., & Feinberg, A. P. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.222538099 · Cited by 573 · see citing works
Substrates and regulation mechanisms for the human mitochondrial sirtuins Sirt3 and Sirt5
Schlicker, C., Gertz, M., Papatheodorou, P., Kachholz, B., Becker, C. F. W., & Steegborn, C. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.07.048 · Cited by 531 · see citing works
Wagner, G. R., & Payne, R. M. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.486753 · Cited by 490 · see citing works
Shimazu, T., Hirschey, M. D., Hua, L., Dittenhafer-Reed, K. E., Schwer, B., Lombard, D. B., Li, Y., Bunkenborg, J., Alt, F. W., Denu, J. M., et al. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.11.003 · Cited by 484 · see citing works
Self-citationNishida, Y., Rardin, M. J., Carrico, C., He, W., Sahu, A. K., Gut, P., Najjar, R., Fitch, M., Hellerstein, M., Gibson, B. W., et al. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.05.022 · Cited by 481 · see citing works
Self-citationProtein Ionizable Groups: pK Values and Their Contribution to Protein Stability and Solubility
Pace, C. N., Grimsley, G. R., & Scholtz, J. M. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.r800080200 · Cited by 456 · see citing works
Rardin, M. J., Newman, J. C., Held, J. M., Cusack, M. P., Sorensen, D. J., Li, B., Schilling, B., Mooney, S. D., Kahn, C. R., Verdin, E. M., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1302961110 · Cited by 446 · see citing works
Self-citationJeong, S. M., Xiao, C., Finley, L. W. S., Lahusen, T., Souza, A. L., Pierce, K., Li, Y.-H., Wang, X., Laurent, G., German, N. J., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.02.024 · Cited by 445 · see citing works
Schilling, B., Rardin, M. J., MacLean, B., Zawadzka, A. M., Frewen, B. E., Cusack, M. P., Sorensen, D. J., Bereman, M. S., Jing, E., Wu, C. C., et al. (2012) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m112.017707 · Cited by 441 · see citing works
Self-citationBell, E. L., Emerling, B. M., Ricoult, S. J. H., & Guarente, L. (2011) · Oncogene · doi:10.1038/onc.2011.37 · Cited by 440 · see citing works
Acetyl-Phosphate Is a Critical Determinant of Lysine Acetylation in E. coli
Weinert, B. T., Iešmantavičius, V., Wagner, S., Scholz, C. W., Gummesson, B., Beli, P., Nyström, T., & Choudhary, C. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.06.003 · Cited by 440 · see citing works
Sirtuin 4 is a lipoamidase regulating pyruvate dehydrogenase complex activity
Mathias, R. A., Greco, T. M., Oberstein, A., Budayeva, H. G., Chakrabarti, R., Rowland, E. A., Kang, Y., Shenk, T., & Cristea, I. M. (2014) · Cell · doi:10.1016/j.cell.2014.11.046 · Cited by 430 · see citing works
Regulation of Insulin Secretion by SIRT4, a Mitochondrial ADP-ribosyltransferase
Ahuja, N., Schwer, B., Carobbio, S., Waltregny, D., North, B. J., Castronovo, V., Maechler, P., & Verdin, E. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m705488200 · Cited by 422 · see citing works
Self-citationLaurent, G., German, N. J., Saha, A. K., de Boer, V. C. J., Davies, M. N., Koves, T. R., Dephoure, N., Fischer, F. F., Boanca, G., Vaitheesvaran, B., et al. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.05.012 · Cited by 394 · see citing works
Sirt3 promotes the urea cycle and fatty acid oxidation during dietary restriction
Hallows, W. C., Yu, W., Smith, B. C., Devires, M. K., Ellinger, J. J., Someya, S., Shortreed, M. R., Prolla, T., Markley, J. L., Smith, L. M., et al. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.01.002 · Cited by 389 · see citing works
Cheng, A., Yang, Y., Zhou, Y., Maharana, C., Lu, D., Peng, W., Liu, Y., Wan, R., Marosi, K., Misiak, M., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2015.10.013 · Cited by 371 · see citing works
SIRT4 is a lysine deacylase that controls leucine metabolism and insulin secretion
Anderson, K. A., Huynh, F. K., Fisher-Wellman, K., Stuart, J. D., Peterson, B. S., Douros, J. D., Wagner, G. R., Thompson, J. W., Madsen, A. S., Green, M. F., et al. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.03.003 · Cited by 326 · see citing works
Quinlan, C. L., Goncalves, R. L. S., Hey-Mogensen, M., Yadava, N., Bunik, V. I., & Brand, M. D. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.545301 · Cited by 310 · see citing works
Fan, J., Shan, C., Kang, H.-B., Elf, S., Xie, J., Tucker, M., Gu, T.-L., Aguiar, M., Lonning, S., Chen, H., et al. (2014) · Molecular Cell · doi:10.1016/j.molcel.2013.12.026 · Cited by 305 · see citing works
Sirt3 regulates metabolic flexibility of skeletal muscle through reversible enzymatic deacetylation
Jing, E., O’Neill, B. T., Rardin, M. J., Kleinridders, A., Ilkeyeva, O. R., Ussar, S., Bain, J. R., Lee, K. Y., Verdin, E. M., Newgard, C. B., et al. (2013) · Diabetes · doi:10.2337/db12-1650 · Cited by 283 · see citing works
Self-citationBrown, K. D., Maqsood, S., Huang, J.-Y., Pan, Y., Harkcom, W., Li, W., Sauve, A., Verdin, E., & Jaffrey, S. R. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.11.003 · Cited by 277 · see citing works
Self-citationThe sirtuins, oxidative stress and aging: an emerging link
Merksamer, P. I., Liu, Y., He, W., Hirschey, M. D., Chen, D., & Verdin, E. (2013) · Aging · doi:10.18632/aging.100544 · Cited by 275 · see citing works
Self-citationAcetylation dynamics and stoichiometry in Saccharomyces cerevisiae
Weinert, B. T., Iešmantavičius, V., Moustafa, T., Scholz, C. W., Wagner, S., Magnes, C., Zechner, R., & Choudhary, C. (2014) · Molecular Systems Biology · doi:10.1002/msb.134766 · Cited by 272 · see citing works
Calorie restriction alters mitochondrial protein acetylation
Schwer, B., Eckersdorff, M., Li, Y., Silva, J. C., Fermin, D., Kurtev, M. V., Giallourakis, C., Comb, M. J., Alt, F. W., & Lombard, D. B. (2009) · Aging Cell · doi:10.1111/j.1474-9726.2009.00503.x · Cited by 259 · cited 1× · see citing works
“Metabolic supplier organs such as the liver and kidney demonstrate mitochondrial hyperacetylation under CR, as does the heart (Schwer et al. 2009); brain mitochondrial acetylation was unchanged, however, and skeletal muscle acetylation decreased.”
BackgroundA Class of Reactive Acyl-CoA Species Reveals the Non-enzymatic Origins of Protein Acylation
Wagner, G. R., Bhatt, D. P., O’Connell, T. M., Thompson, J. W., Dubois, L. G., Backos, D. S., Yang, H., Mitchell, G. A., Ilkayeva, O. R., Stevens, R. D., et al. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.03.006 · Cited by 258 · see citing works
Lee, K., Kerner, J., & Hoppel, C. L. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.228692 · Cited by 254 · see citing works
Role of sirtuins in lifespan regulation is linked to methylation of nicotinamide
Schmeisser, K., Mansfeld, J., Kuhlow, D., Weimer, S., Priebe, S., Heiland, I., Birringer, M., Groth, M., Segref, A., Kanfi, Y., et al. (2013) · Nature Chemical Biology · doi:10.1038/nchembio.1352 · Cited by 236 · see citing works
Requejo, R., Hurd, T. R., Costa, N. J., & Murphy, M. P. (2010) · The FEBS Journal · doi:10.1111/j.1742-4658.2010.07576.x · Cited by 231 · see citing works
Scott, I., Webster, B. R., Li, J. H., & Sack, M. N. (2012) · Biochemical Journal · doi:10.1042/bj20120118 · Cited by 214 · see citing works
Paulin, R., Dromparis, P., Sutendra, G., Gurtu, V., Zervopoulos, S., Bowers, L., Haromy, A., Webster, L., Provencher, S., Bonnet, S., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.08.011 · Cited by 214 · see citing works
Sirtuin-3 (SIRT3), a novel potential therapeutic target for oral cancer
Alhazzazi, T. Y., Kamarajan, P., Joo, N., Huang, J., Verdin, E., D'Silva, N. J., & Kapila, Y. L. (2011) · Cancer · doi:10.1002/cncr.25676 · Cited by 208 · see citing works
Self-citationFunctional Lysine Modification by an Intrinsically Reactive Primary Glycolytic Metabolite
Moellering, R. E., & Cravatt, B. F. (2013) · Science · doi:10.1126/science.1238327 · Cited by 207 · see citing works
Cheng, Y., Ren, X., Gowda, A. S., Shan, Y., Zhang, L., Yuan, Y.-S., Patel, R., Wu, H., Huber-Keener, K., Yang, J. W., et al. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.254 · Cited by 205 · see citing works
Overmyer, K. A., Evans, C. R., Qi, N., Minogue, C. E., Carson, J. J., Chermside‐Scabbo, C. J., Koch, L. G., Britton, S. L., Pagliarini, D. J., Coon, J. J., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.02.007 · Cited by 196 · see citing works
Colak, G., Pougovkina, O., Dai, L., Tan, M., Brinke, H. T., Huang, H., Cheng, Z., Park, J.-S., Wan, X., Liu, X., et al. (2015) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m115.048850 · Cited by 186 · see citing works
Extended wakefulness: compromised metabolics in and degeneration of locus ceruleus neurons
Zhang, J., Zhu, Y., Zhan, G., Fenik, P., Panossian, L., Wang, M. M., Reid, S., Lai, D., Davis, J. G., Baur, J. A., et al. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.5025-12.2014 · Cited by 171 · see citing works
Site-Specific Reactivity of Nonenzymatic Lysine Acetylation
Baeza, J., Smallegan, M. J., & Denu, J. M. (2015) · ACS Chemical Biology · doi:10.1021/cb500848p · Cited by 169 · see citing works
Stoichiometry of site-specific lysine acetylation in an entire proteome
Baeza, J., Dowell, J. A., Smallegan, M. J., Fan, J., Amador-Noguez, D., Khan, Z., & Denu, J. M. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.581843 · Cited by 154 · see citing works
Lantier, L., Williams, A. S., Williams, I. M., Yang, K. K., Bracy, D. P., Goelzer, M., James, F. D., Gius, D., & Wasserman, D. H. (2015) · Diabetes · doi:10.2337/db14-1810 · Cited by 151 · see citing works
Nonenzymatic acetylation of histones with acetyl-CoA
Paik, W. K., Pearson, D., Lee, H. W., & Kim, S. (1970) · Biochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis · doi:10.1016/0005-2787(70)90058-4 · Cited by 151 · see citing works
Meyer, J. G., & Schilling, B. (2017) · Expert Review of Proteomics · doi:10.1080/14789450.2017.1322904 · Cited by 151 · see citing works
Self-citationSol, E.-R. M., Wagner, S., Weinert, B. T., Kumar, A., Kim, H., Deng, C., & Choudhary, C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050545 · Cited by 150 · see citing works
Analysis of acetylation stoichiometry suggests that SIRT3 repairs nonenzymatic acetylation lesions
Weinert, B. T., Moustafa, T., Iešmantavičius, V., Zechner, R., & Choudhary, C. (2015) · The EMBO Journal · doi:10.15252/embj.201591271 · Cited by 150 · see citing works
SIRT3 is Pro-Apoptotic and Participates in Distinct Basal Apoptotic Pathways
Allison, S. J., & Milner, J. (2007) · Cell Cycle · doi:10.4161/cc.6.21.4866 · Cited by 147 · see citing works
Fernandez-Marcos, P. J., Jeninga, E. H., Canto, C., Harach, T., de Boer, V. C. J., Andreux, P., Moullan, N., Pirinen, E., Yamamoto, H., Houten, S. M., et al. (2012) · Scientific Reports · doi:10.1038/srep00425 · Cited by 137 · see citing works
Du, Y., Cai, T., Li, T., Xue, P., Zhou, B., He, X., Peng, W., Liu, P., Yang, F., & Wei, T. (2014) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m114.041947 · Cited by 134 · see citing works
Still, A. J., Floyd, B. J., Hebert, A. S., Bingman, C. A., Carson, J. J., Gunderson, D. R., Dolan, B. K., Grimsrud, P. A., Dittenhafer-Reed, K. E., Stapleton, D. S., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.483396 · Cited by 123 · see citing works
SIRT4 protein suppresses tumor formation in genetic models of Myc-induced B cell lymphoma
Jeong, S. M., Lee, A., Lee, J., & Haigis, M. C. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.525949 · Cited by 121 · see citing works
<i>Drosophila</i> Sirt2/mammalian SIRT3 deacetylates ATP synthase β and regulates complex V activity
Rahman, M., Nirala, N. K., Singh, A., Zhu, L. J., Taguchi, K., Bamba, T., Fukusaki, E., Shaw, L. M., Lambright, D. G., Acharya, J. K., et al. (2014) · Journal of Cell Biology · doi:10.1083/jcb.201404118 · Cited by 116 · see citing works
James, A. M., Hoogewijs, K., Logan, A., Hall, A. R., Ding, S., Fearnley, I. M., & Murphy, M. P. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.02.018 · Cited by 112 · see citing works
Acetate kinase: not just a bacterial enzyme
Ingram-Smith, C. J., Martin, S. R., & Smith, K. S. (2006) · Trends in Microbiology · doi:10.1016/j.tim.2006.04.001 · Cited by 111 · see citing works
Matsushita, N., Yonashiro, R., Ogata, Y., Sugiura, A., Nagashima, S., Fukuda, T., Inatome, R., & Yanagi, S. (2011) · Genes to Cells · doi:10.1111/j.1365-2443.2010.01475.x · Cited by 106 · see citing works
Pannek, M., Simic, Z., Fuszard, M. A., Meleshin, M., Rotili, D., Mai, A., Schutkowski, M., & Steegborn, C. (2017) · Nature Communications · doi:10.1038/s41467-017-01701-2 · Cited by 102 · see citing works
Weinert, B. T., Satpathy, S., Hansen, B. K., Lyon, D. B., Jensen, L. J., & Choudhary, C. (2017) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m117.067587 · Cited by 98 · see citing works
Amigo, I., Menezes‐Filho, S. L., Luévano‐Martínez, L. A., Chausse, B., & Kowaltowski, A. J. (2017) · Aging Cell · doi:10.1111/acel.12527 · Cited by 95 · see citing works
Aberrant protein acylation is a common observation in inborn errors of acyl-CoA metabolism
Pougovkina, O., te Brinke, H., Wanders, R. J. A., Houten, S. M., & de Boer, V. C. J. (2014) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-014-9684-9 · Cited by 80 · see citing works
SIRT3 substrate specificity determined by peptide arrays and machine learning
Smith, B. C., Settles, B., Hallows, W. C., Craven, M. W., & Denu, J. M. (2011) · ACS Chemical Biology · doi:10.1021/cb100218d · Cited by 80 · see citing works
Meyer, J. G., D’Souza, A. K., Sorensen, D. J., Rardin, M. J., Wolfe, A. J., Gibson, B. W., & Schilling, B. (2016) · Journal of the American Society for Mass Spectrometry · doi:10.1007/s13361-016-1476-z · Cited by 79 · see citing works
Self-citationRardin, M. J., Schilling, B., Cheng, L.-Y., MacLean, B., Sorensen, D. J., Sahu, A. K., MacCoss, M. J., Olga Vitek, A., & Gibson, B. W. (2015) · Molecular & Cellular Proteomics · doi:10.1074/mcp.o115.048181 · Cited by 66 · see citing works
Self-citationMielke, C., Lefort, N., McLean, C. G., Cordova, J. M., Langlais, P. R., Bordner, A. J., Te, J. A., Ozkan, S. B., Willis, W. T., & Mandarino, L. J. (2014) · Biochemistry · doi:10.1021/bi401651e · Cited by 53 · see citing works
Khan, A. N., & Lewis, P. N. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m508247200 · Cited by 43 · see citing works
Site-Specific Identification of Lysine Acetylation Stoichiometries in Mammalian Cells
Zhou, T., Chung, Y., Chen, J., & Chen, Y. (2016) · Journal of Proteome Research · doi:10.1021/acs.jproteome.5b01097 · Cited by 41 · see citing works
A Method to Determine Lysine Acetylation Stoichiometries
Nakayasu, E. S., Wu, S., Sydor, M. A., Shukla, A. K., Weitz, K., Moore, R. J., Hixson, K. K., Kim, J., Petyuk, V., Monroe, M. E., et al. (2014) · International Journal of Proteomics · doi:10.1155/2014/730725 · Cited by 37 · see citing works
Erratum To: Acetylation dynamics and stoichiometry in Saccharomyces cerevisiae
Weinert, B. T., Iešmantavičius, V., Moustafa, T., Schölz, C., Wagner, S., Magnes, C., Zechner, R., & Choudhary, C. (2015) · Molecular Systems Biology · doi:10.15252/msb.156513 · Cited by 37 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
NAD+ metabolism and its roles in cellular processes during ageing
Covarrubias, A. J., Perrone, R., Grozio, A., & Verdin, E. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-00313-x · Cited by 1,617 · see citing works
Self-citationFrom discoveries in ageing research to therapeutics for healthy ageing
Campisi, J., Kapahi, P., Lithgow, G. J., Melov, S., Newman, J. C., & Verdin, E. (2019) · Nature · doi:10.1038/s41586-019-1365-2 · Cited by 1,389 · see citing works
Self-citationFunctions and mechanisms of non-histone protein acetylation
Narita, T., Weinert, B. T., & Choudhary, C. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0081-3 · Cited by 1,232 · see citing works
NAD+ metabolism: pathophysiologic mechanisms and therapeutic potential
Xie, N., Zhang, L., Gao, W. Q., Huang, C., Huber, P., Zhou, X., Li, C. L., Shen, G., & Zou, B. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00311-7 · Cited by 1,076 · see citing works
Mitochondrial dysfunction in pathophysiology of heart failure
Zhou, B., & Tian, R. (2018) · Journal of Clinical Investigation · doi:10.1172/jci120849 · Cited by 934 · see citing works
Metabolic reprogramming and epigenetic modifications on the path to cancer
Sun, L., Zhang, H., & Gao, P. (2021) · Protein & Cell · doi:10.1007/s13238-021-00846-7 · Cited by 796 · see citing works
Mitochondrial signal transduction
Picard, M. A., & Shirihai, O. S. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.10.008 · Cited by 666 · see citing works
Compartmentalised acyl-CoA metabolism and roles in chromatin regulation
Trefely, S., Lovell, C. D., Snyder, N. W., & Wellen, K. E. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.01.005 · Cited by 272 · see citing works
SENP1-Sirt3 Signaling Controls Mitochondrial Protein Acetylation and Metabolism
Wang, T., Cao, Y., Zheng, Q., Tu, J., Zhou, W., He, J., Zhong, J., Chen, Y., Wang, J., Cai, R., et al. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.06.008 · Cited by 250 · see citing works
Pellagatti, A., Armstrong, R. N., Steeples, V., Sharma, E., Repapi, E., Singh, S., Sanchi, A., Radujkovic, A., Horn, P., Dolatshad, H., et al. (2018) · Blood · doi:10.1182/blood-2018-04-843771 · Cited by 240 · see citing works
Malonylation of GAPDH is an inflammatory signal in macrophages
Galván-Peña, S., Carroll, R. G., Newman, C. F., Hinchy, E. C., Pålsson‐McDermott, E. M., Robinson, E. K., Covarrubias, S., Nadin, A. J., James, A. M., Haneklaus, M., et al. (2019) · Nature Communications · doi:10.1038/s41467-018-08187-6 · Cited by 213 · see citing works
Regulation of UCP1 and Mitochondrial Metabolism in Brown Adipose Tissue by Reversible Succinylation
Wang, G., Meyer, J. G., Cai, W., Softic, S., Li, M. E., Verdin, E. M., Newgard, C. B., Schilling, B., & Kahn, C. R. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.03.021 · Cited by 213 · see citing works
Self-citationMitochondrial-derived vesicles in metabolism, disease, and aging
König, T., & McBride, H. M. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2023.11.014 · Cited by 189 · see citing works
Mitochondrial Transfer and Regulators of Mesenchymal Stromal Cell Function and Therapeutic Efficacy
Mohammadalipour, A., Dumbali, S. P., & Wenzel, P. L. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.603292 · Cited by 176 · see citing works
Xin, T., & Lu, C. (2020) · Aging · doi:10.18632/aging.103644 · Cited by 171 · see citing works
Yang, G., Yuan, Y., Yuan, H., Wang, J., Yun, H., Geng, Y., Zhao, M., Li, L., Weng, Y., Liu, Z., et al. (2020) · EMBO Reports · doi:10.15252/embr.202050967 · Cited by 165 · see citing works
He, J., Shangguan, X., Zhou, W., Cao, Y., Zheng, Q., Tu, J., Hu, G., Liang, Z., Jiang, C., Deng, L., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24619-2 · Cited by 153 · see citing works
Peng, F., Liao, M., Jin, W., Liu, W., Li, Z., Fan, Z., Zou, L., Chen, S., Zhu, L., Zhao, Q., et al. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01816-1 · Cited by 147 · see citing works
Ketogenesis impact on liver metabolism revealed by proteomics of lysine β-hydroxybutyrylation
Koronowski, K. B., Greco, C. M., Huang, H., Kim, J., Fribourgh, J. L., Crosby, P., Mathur, L., Ren, X., Partch, C. L., Jang, C., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109487 · Cited by 141 · see citing works
Proteomics in aging research: A roadmap to clinical, translational research
Moaddel, R., Ubaida‐Mohien, C., Tanaka, T., Lyashkov, A., Basisty, N., Schilling, B., Semba, R. D., Franceschi, C., Gorospe, M., & Ferrucci, L. (2021) · Aging Cell · doi:10.1111/acel.13325 · Cited by 139 · see citing works
The Roles of Mitochondrial SIRT4 in Cellular Metabolism
Min, Z., Gao, J., & Yu, Y. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00783 · Cited by 135 · see citing works
SENP1-Sirt3 signaling promotes α-ketoglutarate production during M2 macrophage polarization
Zhou, W., Hu, G., He, J., Wang, T., Zuo, Y., Cao, Y., Zheng, Q., Tu, J., Ma, J., Cai, R., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110660 · Cited by 126 · see citing works
Melatonin Mitigates Mitochondrial Meltdown: Interactions with SIRT3
Reiter, R. J., Tan, D. X., Rosales‐Corral, S., Galano, A., Jou, M., & Acuña-Castroviejo, D. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19082439 · Cited by 124 · see citing works
The Role of SIRT3 in Exercise and Aging
Zhou, L., Pinho, R. A., Gu, Y., & Radak, Z. O. (2022) · Cells · doi:10.3390/cells11162596 · Cited by 124 · see citing works
Gallo, G., Rubattu, S. D., & Volpe, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052667 · Cited by 120 · see citing works
The role of SIRT3-mediated mitochondrial homeostasis in osteoarthritis
He, Y., Wu, Z., Xu, L., Xu, K., Chen, Z., Ran, J., & Wu, L. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03497-9 · Cited by 106 · see citing works
Wang, C., & Wei, Y. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155266 · Cited by 95 · see citing works
Role of miR-2392 in driving SARS-CoV-2 infection
McDonald, J. T., Enguita, F. J., Taylor, D. M., Griffin, R. J., Priebe, W., Emmett, M. R., Sajadi, M. M., Harris, A. D., Clement, J., Dybas, J. M., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109839 · Cited by 93 · see citing works
Cheng, A., Wang, J., Ghena, N., Zhao, Q., Perone, I., King, T. M., Veech, R. L., Gorospe, M., Wan, R., & Mattson, M. P. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.1446-19.2019 · Cited by 91 · see citing works
Chen, X., Hao, B., Li, D. X., Reiter, R. J., Bai, Y., Abay, B., Chen, G., Lin, S., Zheng, T., Ren, Y., et al. (2021) · Journal of Pineal Research · doi:10.1111/jpi.12755 · Cited by 92 · see citing works
Global Metabolic Shifts in Age and Alzheimer’s Disease Mouse Brains Pivot at NAD + /NADH Redox Sites
Dong, Y., & Brewer, G. J. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190408 · Cited by 90 · see citing works
Møller, I. M., Igamberdiev, A. U., Bykova, N. V., Finkemeier, I., Rasmusson, A. G., & Schwarzländer, M. (2020) · The Plant Cell · doi:10.1105/tpc.19.00535 · Cited by 89 · see citing works
Sun, Y., Yang, Y.-M., Hu, Y.-Y., Ouyang, L., Sun, Z., Yin, X., Li, N., He, Q., & Wang, Y. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102334 · Cited by 90 · see citing works
CPLM 4.0: an updated database with rich annotations for protein lysine modifications
Zhang, W., Tan, X., Lin, S., Gou, Y., Han, C., Zhang, C., Ning, W., Wang, C., & Xue, Y. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab849 · Cited by 89 · see citing works
Histone deacetylases control lysine acetylation of ribosomal proteins in rice
Xu, Q., Liu, Q., Chen, Z., Yue, Y., Liu, Y., Zhao, Y. J., & Zhou, D. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab244 · Cited by 87 · see citing works
Thapa, D., Wu, K., Stoner, M. W., Xie, B., Zhang, M., Manning, J. R., Lu, Z., Li, J. H., Chen, Y., Guček, M., et al. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ac118.005462 · Cited by 85 · see citing works
Gut, P., Matilainen, S., Meyer, J. G., Pällijeff, P., Richard, J., Carroll, C. J., Euro, L., Jackson, C. B., Isohanni, P., Minassian, B. A., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19743-4 · Cited by 83 · see citing works
Self-citationZhang, W., & Lang, R. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1266973 · Cited by 78 · see citing works
The mitochondrial multi-omic response to exercise training across rat tissues
Amar, D., Gay, N. R., Jimenez‐Morales, D., Beltran, P. M. J., Ramaker, M. E., Raja, A. N., Zhao, B., Sun, Y., Marwaha, S., Gaul, D. A., et al. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2023.12.021 · Cited by 81 · see citing works
Betsinger, C. N., & Cristea, I. M. (2019) · Journal of Proteome Research · doi:10.1021/acs.jproteome.9b00086 · Cited by 80 · see citing works
Dikalov, S., & Dikalova, A. (2019) · Antioxidants and Redox Signaling · doi:10.1089/ars.2018.7632 · Cited by 79 · see citing works
Extreme Acetylation of the Cardiac Mitochondrial Proteome Does Not Promote Heart Failure
Davidson, M. T., Grimsrud, P. A., Lai, L., Draper, J. A., Fisher‐Wellman, K. H., Narowski, T. M., Abraham, D., Koves, T. R., Kelly, D. P., & Muoio, D. M. (2020) · Circulation Research · doi:10.1161/circresaha.120.317293 · Cited by 76 · see citing works
Chen, Y., Wu, Y., Si, H., Lu, Y., & Shen, B. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105497 · Cited by 77 · see citing works
Sirtuin5 protects colorectal cancer from DNA damage by keeping nucleotide availability
Wang, H.-L., Chen, Y., Wang, Y.-Q., Tan, J., Tan, J., Liu, Q., Li, C.-M., Tong, X., Gao, Q., Hong, J., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-33903-8 · Cited by 78 · see citing works
HDAC1/2/3 are major histone desuccinylases critical for promoter desuccinylation
Li, J., Lu, L., Liu, L., Ren, X., Chen, J., Yin, X., Xiao, Y., Li, J., Wei, G., Huang, H., et al. (2023) · Cell Discovery · doi:10.1038/s41421-023-00573-9 · Cited by 76 · see citing works
Melatonin ameliorates cerebral ischemia/reperfusion injury through SIRT3 activation
Liu, L., Chen, H., Jin, J., Tang, Z., Yin, P., Zhong, D., & Li, G. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.117036 · Cited by 72 · see citing works
What Room for Two-Dimensional Gel-Based Proteomics in a Shotgun Proteomics World?
Marcus, K., Lelong, C., & Rabilloud, T. (2020) · Proteomes · doi:10.3390/proteomes8030017 · Cited by 62 · see citing works
Pptc7 is an essential phosphatase for promoting mammalian mitochondrial metabolism and biogenesis
Niemi, N. M., Wilson, G. M., Overmyer, K. A., Vögtle, F. ‐., Myketin, L., Lohman, D. C., Schueler, K. L., Attie, A., Meisinger, C., Coon, J. J., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11047-6 · Cited by 71 · see citing works
CD38 Mediates Lung Fibrosis by Promoting Alveolar Epithelial Cell Aging
Cui, H., Xie, N., Banerjee, S., Dey, T., Liu, R.-M., Antony, V. B., Sanders, Y. Y., Adams, T. S., Gómez, J. L., Thannickal, V. J., et al. (2022) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202109-2151oc · Cited by 70 · see citing works
SIRT4 and Its Roles in Energy and Redox Metabolism in Health, Disease and During Exercise
Han, Y., Zhou, S., Coetzee, S., & Chen, A. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.01006 · Cited by 69 · see citing works
SIRT5 Is a Druggable Metabolic Vulnerability in Acute Myeloid Leukemia
Yan, D., Franzini, A., Pomicter, A. D., Halverson, B. J., Antelope, O., Mason, C. C., Ahmann, J. M., Senina, A. V., Vellore, N. A., Jones, C. L., et al. (2021) · Blood Cancer Discovery · doi:10.1158/2643-3230.bcd-20-0168 · Cited by 66 · see citing works
Lin, S., Wu, B., Hu, X., & Lu, H. (2024) · International Journal of Biological Sciences · doi:10.7150/ijbs.85585 · Cited by 67 · see citing works
Targeting glutamine metabolism in hepatic stellate cells alleviates liver fibrosis
Yin, X.-C., Peng, J., Gu, L.-H., Liu, Y., Li, X., Wu, J.-H., Xu, B., Zhuge, Y., & Zhang, F. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05409-0 · Cited by 62 · see citing works
Tataranni, T., Agriesti, F., Pacelli, C., Ruggieri, V., Laurenzana, I., Mazzoccoli, C., Sala, G. D., Panebianco, C., Pazienza, V., Capitanio, N., et al. (2019) · Cells · doi:10.3390/cells8050478 · Cited by 65 · see citing works
Palmieri, F., Monné, M., Fiermonte, G., & Palmieri, L. (2022) · IUBMB Life · doi:10.1002/iub.2612 · Cited by 66 · see citing works
The balance between NAD+ biosynthesis and consumption in ageing
Strømland, Ø., Diab, J., Ferrario, E., Sverkeli, L. J., & Ziegler, M. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111569 · Cited by 63 · see citing works
PPARγ agonists delay age‐associated metabolic disease and extend longevity
Xu, L., Ma, X., Verma, N., Pèrié, L., Pendse, J., Shamloo, S., Josephson, A. M., Wang, D., Qiu, J., Guo, M., et al. (2020) · Aging Cell · doi:10.1111/acel.13267 · Cited by 63 · see citing works
Mitochondrial Sirtuins and Doxorubicin-induced Cardiotoxicity
He, L., Liu, F., & Li, J. (2021) · Cardiovascular Toxicology · doi:10.1007/s12012-020-09626-x · Cited by 60 · see citing works
Xia, X., Liu, Y., Lu, Y., Liu, J., Deng, Y., Wu, Y., Hou, M., He, F., Yang, H., Xu, Y. X., et al. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202302475 · Cited by 59 · see citing works
Molecular and cellular regulatory roles of sirtuin protein
Pande, S., & Raisuddin, S. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2070722 · Cited by 58 · see citing works
Liu, L., Xie, Y., Li, G., Zhang, T., Sui, Y., Zhao, Z., Zhang, Y., Yang, W., Geng, X., Xue, D., et al. (2023) · British Journal of Pharmacology · doi:10.1111/bph.15980 · Cited by 56 · see citing works
Tao, J. Z., Li, J., Fan, X., Jiang, C. Q., Wang, Y., Qin, M., Nikfard, F., Nikfard, F., Wang, Y., Zhao, T., et al. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102489 · Cited by 56 · see citing works
Woods, D. C., Khrapko, K., & Tilly, J. L. (2018) · Genes · doi:10.3390/genes9050265 · Cited by 58 · see citing works
Williams, A. S., Koves, T. R., Davidson, M. T., Crown, S. B., Fisher‐Wellman, K. H., Torres, M. J., Draper, J. A., Narowski, T. M., Slentz, D. H., Lantier, L., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.11.003 · Cited by 55 · see citing works
Decoding the Rosetta stone of mitonuclear communication
English, J., Son, J. M., Cardamone, M. D., Lee, C., & Perissi, V. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105161 · Cited by 55 · see citing works
AGO2 Protects Against Diabetic Cardiomyopathy by Activating Mitochondrial Gene Translation
Zhan, J., Jin, K., Xie, R., Fan, J., Tang, Y., Chen, C., Li, H., & Wang, D. W. (2023) · Circulation · doi:10.1161/circulationaha.123.065546 · Cited by 56 · see citing works
Baldensperger, T., Eggen, M., Kappen, J., Winterhalter, P. R., Pfirrmann, T., & Glomb, M. A. (2020) · Scientific Reports · doi:10.1038/s41598-020-64265-0 · Cited by 54 · see citing works
Sun, Y., Xie, Z., Jin, L., Qin, T., Zhan, C., & Huang, J. (2024) · The Plant Cell · doi:10.1093/plcell/koae010 · Cited by 54 · see citing works
The Mystery of Extramitochondrial Proteins Lysine Succinylation
Chinopoulos, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22116085 · Cited by 42 · see citing works
Mitochondrial Sirtuins in Parkinson’s Disease
He, L., Wang, J., Yang, Y., Li, J., & Tu, H. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03560-w · Cited by 53 · see citing works
NAD+ metabolism-based immunoregulation and therapeutic potential
Fang, J., Chen, W., Hou, P., Liu, Z., Zuo, M., Liu, S., Feng, C., Han, Y., Li, P., Shi, Y., et al. (2023) · Cell & Bioscience · doi:10.1186/s13578-023-01031-5 · Cited by 54 · see citing works
Head, P. E., Myung, S., Chen, Y., Schneller, J. L., Wang, C., Duncan, N., Hoffman, P., Chang, D., Gebremariam, A., Gucek, M., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abn4772 · Cited by 52 · see citing works
Li, Y., Wei, X., Liu, S., Zhao, Y., Jin, S., & Yang, X. (2021) · Phytotherapy Research · doi:10.1002/ptr.7175 · Cited by 52 · see citing works
SIRT3 regulates mitochondrial biogenesis in aging-related diseases
Li, H., & Cai, Z. (2022) · Journal of Biomedical Research · doi:10.7555/jbr.36.20220078 · Cited by 51 · see citing works
Epigenetic Regulation of Metabolism and Inflammation by Calorie Restriction
Hernández‐Saavedra, D., Moody, L., Xu, G. B., Chen, H., & Pan, Y. (2018) · Advances in Nutrition · doi:10.1093/advances/nmy129 · Cited by 51 · see citing works
Molecular basis for t6A modification in human mitochondria
Zhou, J.-B., Wang, Y., Zeng, Q., Meng, S.-X., Wang, E., & Zhou, X.-L. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa093 · Cited by 51 · see citing works
Organic acidurias: Major gaps, new challenges, and a yet unfulfilled promise
Dimitrov, B., Molema, F., Williams, M., Schmiesing, J., Mühlhausen, C., Baumgartner, M. R., Schumann, A., & Kölker, S. (2020) · Journal of Inherited Metabolic Disease · doi:10.1002/jimd.12254 · Cited by 51 · see citing works
SIRT1/SIRT3 Modulates Redox Homeostasis during Ischemia/Reperfusion in the Aging Heart
Zhang, J., Ren, D., Fedorova, J., He, Z., & Li, J. (2020) · Antioxidants · doi:10.3390/antiox9090858 · Cited by 50 · see citing works
Imbalance of Lysine Acetylation Contributes to the Pathogenesis of Parkinson’s Disease
Wang, R., Sun, H., Wang, G., & Ren, H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197182 · Cited by 50 · see citing works
Stamerra, C. A., Di Giosia, P., Giorgini, P., Ferri, C., Sukhorukov, V. N., & Sahebkar, A. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/9530007 · Cited by 48 · see citing works
RetractedLoss of Mitochondrial Control Impacts Renal Health
Srivastava, S. P., Kanasaki, K., & Goodwin, J. E. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.543973 · Cited by 46 · see citing works
SIRT4 Suppresses Doxorubicin-Induced Cardiotoxicity by Regulating the AKT/mTOR/Autophagy Pathway
He, L., Wang, J., Yang, Y., Zou, P., Xia, Z., & Li, J. (2022) · Toxicology · doi:10.1016/j.tox.2022.153119 · Cited by 46 · see citing works
Mechanisms of metabolism-coupled protein modifications
Zhang, B., & Schroeder, F. C. (2025) · Nature Chemical Biology · doi:10.1038/s41589-024-01805-z · Cited by 46 · see citing works
Zhu, S., Mąkosa, D., Miller, B. F., & Griffin, T. M. (2019) · Connective Tissue Research · doi:10.1080/03008207.2019.1665035 · Cited by 44 · see citing works
Min, Z., Long, X., Zhao, H., Zhen, X., Li, R., Li, M., Fan, Y., Yu, Y., Zhao, Y., & Qiao, J. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.567028 · Cited by 43 · see citing works
Yan, B., Liu, Q., Ding, X., Lin, Y., Jiao, X., Wu, Y., Miao, H., & Zhou, C. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/4722647 · Cited by 42 · see citing works
Liao, Y., Ke, B., Long, X., Xu, J., & Wu, Y. (2023) · BMC Cardiovascular Disorders · doi:10.1186/s12872-023-03603-2 · Cited by 41 · see citing works
Balancing NAD+ deficits with nicotinamide riboside: therapeutic possibilities and limitations
Cercillieux, A., Ciarlo, E., & Cantó, C. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04499-5 · Cited by 41 · see citing works
Novel Thermosensitive Hydrogel Promotes Spinal Cord Repair by Regulating Mitochondrial Function
Li, Y., Yang, L., Hu, F., Xu, J., Ye, J., Liu, S., Wang, L., Zhuo, M., Ran, B., Zhang, H., et al. (2022) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.2c04341 · Cited by 40 · see citing works
SIRT5 Inhibition Induces Brown Fat-Like Phenotype in 3T3-L1 Preadipocytes
Molinari, F., Feraco, A., Mirabilii, S., Saladini, S., Sansone, L., Vernucci, E., Tomaselli, G., Marzolla, V., Rotili, D., Russo, M. A., et al. (2021) · Cells · doi:10.3390/cells10051126 · Cited by 40 · see citing works
Li, Y., Kong, E., Ding, R., Chu, R., Lu, J., Deng, M., Tong, H., Yang, M., Wang, H., Chen, D., et al. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14913 · Cited by 40 · see citing works
The Causes and Consequences of Nonenzymatic Protein Acylation
James, A. M., Smith, C. L., Smith, A. C., Robinson, A. J., Hoogewijs, K., & Murphy, M. P. (2018) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2018.07.002 · Cited by 39 · see citing works
Metabolism, Epigenetics, and Causal Inference in Heart Failure
Kimball, T. H., & Vondriska, T. M. (2019) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2019.11.009 · Cited by 40 · see citing works
NAD+ centric mechanisms and molecular determinants of skeletal muscle disease and aging
Wagner, S., Manickam, R., Brotto, M. A. P., & Tipparaju, S. M. (2022) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-022-04408-1 · Cited by 39 · see citing works
New insights into the pathophysiology of methylmalonic acidemia
Head, P. E., Meier, J. L., & Venditti, C. P. (2023) · Journal of Inherited Metabolic Disease · doi:10.1002/jimd.12617 · Cited by 40 · see citing works
Sirtuin 3 (SIRT3) Pathways in Age-Related Cardiovascular and Neurodegenerative Diseases
Silaghi, C. N., Farcas, M. F., & Craciun, A. M. (2021) · Biomedicines · doi:10.3390/biomedicines9111574 · Cited by 37 · see citing works
Endothelial SIRT1 as a Target for the Prevention of Arterial Aging: Promises and Challenges
Begum, M. K., Konja, D., Singh, S., Chłopicki, S., & Wang, Y. (2021) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000001154 · Cited by 40 · see citing works
The Zinc-dependent HDACs: Non-histone Substrates and Catalytic Deacylation Beyond Deacetylation
Zheng, W. (2022) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557522666220330144151 · Cited by 37 · see citing works
Amino acids downregulate SIRT4 to detoxify ammonia through the urea cycle
Hu, S.-H., Feng, Y.-Y., Yang, Y.-X., Ma, H., Zhou, S.-X., Qiao, Y.-N., Zhang, K.-H., Zhang, L., Huang, L., Yuan, Y., et al. (2023) · Nature Metabolism · doi:10.1038/s42255-023-00784-0 · Cited by 40 · see citing works
Enzymatic and nonenzymatic protein acetylations control glycolysis process in liver diseases
Li, J., Wang, T., Xia, J., Yao, W., & Huang, F. (2019) · The FASEB Journal · doi:10.1096/fj.201901175r · Cited by 36 · see citing works
- Authors
- Carrico, C., Meyer, J. G., He, W., Gibson, B. W., & Verdin, E.
- Affiliations
- Gladstone Institutes (US)
- Buck Institute for Research on Aging (US)
- Corresponding author
- Verdin, Eric
- Venue
- Cell Metabolism
- Publisher
- Elsevier BV
- Published
- 2018-03
- Volume
- 27
- Issue
- 3
- Pages
- 497-512
- ISSN
- 1550-4131 (ISSN-L)
- PMC
- PMC5863732
- OpenAlex
- W2793563787
- Cited by
- 331
- References
- 103
- Citations by year
- 2026: 26 · 2025: 42 · 2024: 36 · 2023: 46 · 2022: 49 · 2021: 47 · 2020: 38 · 2019: 32 · 2018: 15
- FWCI
- 3.73
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- NIDDK (R24 DK085610)
- NIH (T32 AG000266)
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Health Sciences › Medicine › Epidemiology › Autophagy in Disease and Therapy
- Keywords
- protein acetylation, succinylation, SIRT3, SIRT5, mitochondrial function, metabolic regulation, mitochondrial disease
- MeSH terms
- Acetylation, Acylation, Animals, Humans, Mitochondria, Protein Processing, Post-Translational, Mitochondrial Proteins, Sirtuins, Proteomics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-06.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-06.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review